Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3019050	s-ttgaba	— (—)	74892	94280	100.00%	Distribution not available
3019050	s-ttgaba	u/ml (u/ml)	23502	27796	0.04%
3019050	s-ttgaba	eliau/ml (u/ml)	2579	2712	0.00%
3019050	s-kudostransglutaminaasi,igavasta-aineet	— (—)	535	547	100.00%	Distribution not available
3019050	s-kudostransglutaminaasi,igavasta-aineet	u/ml (u/ml)	450	463	0.00%
3019050	s-kudostransglutaminaasi,iga-vasta-aineet	— (—)	217	222	100.00%	Distribution not available
3019050	kudostransglutaminaasi,igavasta-aineet	u/ml (u/ml)	68	69	0.00%
3019050	s-ttgaba,s-kudostransglutaminaasi,igavasta-aineet	— (—)	52	54	100.00%	Distribution not available
3019050	s-kudostransglutaminaasi,iga-vasta-aineet	u/ml (u/ml)	23	23	0.00%
3019050	kudostransglutaminaasi,igavasta-aineet	— (—)	22	22	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Dentofacial anomalies [including malocclusion]

11589

66107

1.57

322.03

1.3

1.23

1.71

u/ml

5.46

3332

18334

Sleep apnoea

13282

61987

1.51

314.45

1.3

1.25

1.81

u/ml

8.77

3763

16793

Other diseases of hard tissues of teeth

8140

27227

1.69

310.56

1.3

1.2

1.82

1.86

u/ml

0.08

2008

7586

Other and unspecified polyneuropathies, also in other diseases

2588

12511

2.55

308.88

1.4

1.2

1.39

1.97

u/ml

1.66

583

3216

ILD medications: immunosuppressive drugs

9733

62617

1.60

308.66

1.3

1.24

1.78

u/ml

6.07

2590

17307

ILD medications

18274

71530

1.51

307.65

1.3

1.35

1.82

u/ml

6.22

4873

19658

All anxiety disorders

11676

57366

1.88

307.65

1.4

1.3

1.38

1.73

u/ml

2.32

2914

16604

Hypothyroidism, strict autoimmune, 3 medication purchases required

13265

63202

1.56

307.65

1.4

1.3

1.42

1.60

u/ml

1.07

3943

16935

Iron deficiency anaemia

6672

36492

2.15

307.65

1.4

1.3

1.89

1.68

u/ml

0.55

1720

9589

Osteoporosis

3905

18518

2.44

307.65

1.4

1.2

1.22

1.74

u/ml

2.87

1161

4442

First line medication for Crohn's disease

17669

70068

1.48

307.65

1.3

1.32

1.83

u/ml

7.38

4727

19341

Lower back pain or/and sciatica

17294

76508

1.64

307.65

1.3

1.40

1.72

u/ml

2.84

4932

20770

Hypothyroidism, other/unspecified

14533

64284

1.66

307.65

1.4

1.3

1.45

1.64

u/ml

1.22

4275

17231

Hypothyroidism (congenital or acquired)

5555

14341

2.73

307.65

1.4

1.2

1.46

1.99

u/ml

2.54

1752

4319

Insulin, fast-acting (human)

3336

12220

4.30

307.65

1.9

1.2

2.21

1.60

u/ml

1.55

1085

3404

Dorsalgia

16835

59781

1.68

307.65

1.3

1.44

1.85

u/ml

3.79

4806

16222

Endocrine, nutritional and metabolic diseases

14809

46531

1.83

307.65

1.4

1.2

1.73

1.82

u/ml

0.33

4161

12704

Gastro-oesophageal reflux disease

11495

54952

2.14

307.65

1.4

1.3

1.69

1.68

u/ml

0.05

2776

15327

Migraine

9490

48388

1.87

307.65

1.4

1.3

1.35

1.77

u/ml

2.87

2656

13379

Diseases of the musculoskeletal system and connective tissue

9484

31460

1.67

307.65

1.3

1.53

2.01

u/ml

2.84

2623

8491

Diarrhoea and gastroenteritis of presumed infectious origin

17603

73877

1.78

307.65

1.4

1.3

1.50

1.77

u/ml

1.91

4975

19934

Opioids

16019

59162

1.53

307.65

1.3

1.46

1.74

u/ml

2.02

4338

16708

Any reimbursement code in KELA

10699

36677

1.62

307.65

1.4

1.2

1.54

1.86

u/ml

1.67

2972

10362

Tramadol

12067

49347

1.66

307.65

1.3

1.45

1.76

u/ml

1.74

3035

13989

Neurological diseases

14711

50293

1.62

307.65

1.3

1.45

1.87

u/ml

3.72

4076

13658

Insulin, fast-acting

7358

31329

3.24

307.65

1.9

1.2

2.03

1.73

u/ml

1.04

2301

8286

Selective serotonin reuptake inhibitors

16198

55761

1.68

307.65

1.3

1.33

1.92

u/ml

7.72

4230

15482

Pain in joint

10727

34762

2.35

307.65

1.4

1.3

1.58

2.01

u/ml

2.21

2713

9539

Aplastic and other anaemias

5985

32997

1.92

307.65

1.3

1.70

1.75

u/ml

0.10

1337

8428

Other soft tissue disorders, not elsewhere classified

16216

60135

1.79

307.65

1.3

1.39

1.81

u/ml

4.32

4267

16432

Coeliac disease

3008

10815

5.00

307.65

2.3

1.3

12.87

1.24

u/ml

78.56

1329

2751

Osteopathies and chondropathies

8240

49676

1.75

307.65

1.4

1.3

1.41

1.69

u/ml

1.54

2270

12999

Parasetamol

12753

42619

1.67

307.65

1.3

1.39

1.99

u/ml

6.21

3639

11385

Behavioural syndromes associated with physiological disturbances and physical factors

15874

74274

1.72

307.65

1.4

1.3

1.27

1.79

u/ml

7.63

4546

20068

Inflammatory bowel disease treatment related agents

18662

73445

1.56

307.65

1.3

1.36

1.80

u/ml

5.70

5040

20081

Type 1 diabetes, strict (exclude DM2)

2779

9609

5.61

307.65

2.2

1.3

2.38

1.91

u/ml

0.82

816

2536

Neurotic, stress-related and somatoform disorders

15747

71382

1.76

307.65

1.4

1.3

1.47

1.75

u/ml

1.92

4018

20020

Mood disorders, excluding more controls

16307

60886

1.82

307.65

1.3

1.39

1.76

u/ml

3.25

4099

17253

Sleep disorders

15067

72583

1.69

307.65

1.3

1.23

1.75

u/ml

7.77

4379

19720

Hypothyreosis and Thyroxine purchase for inclusion criteria

14968

66941

1.63

307.65

1.4

1.3

1.45

1.64

u/ml

1.36

4392

17894

Diabetes, varying definitions

16022

67450

1.52

307.65

1.5

1.2

1.78

1.69

u/ml

0.32

4589

18401

Asthma (only as main-diagnosis), excluding more controls

11371

43452

1.66

307.65

1.3

1.46

1.81

u/ml

2.28

3219

12311

Diabetes, insulin treatment (Kela reimbursement)

15294

63741

1.59

307.65

1.5

1.2

1.79

1.75

u/ml

0.10

4368

17201

Diarrhoea and gastroenteritis of presumed infectious origin

11038

69337

1.58

307.65

1.4

1.3

1.55

1.74

u/ml

0.82

2983

19023

Psychiatric diseases

15288

54238

1.53

307.65

1.3

1.57

1.87

u/ml

1.94

4114

15018

Diabetic maculopathy, excluding more controls

1831

7533

3.28

307.65

1.9

1.2

1.94

1.99

u/ml

0.06

620

1949

Other anxiety disorders

8717

46935

1.90

307.65

1.4

1.3

1.34

1.69

u/ml

2.12

2106

13710

Other and unspecified dermatitis

7984

50261

1.82

307.65

1.4

1.3

1.58

1.63

u/ml

0.14

2276

13595

Anxiety disorders

15842

71679

1.75

307.65

1.4

1.3

1.46

1.75

u/ml

2.03

4049

20086

Asthma (mode)

12686

45202

1.67

307.65

1.3

1.46

1.82

u/ml

2.45

3546

12779

Persons encountering health services in other circumstances, wide

18640

68189

1.53

307.65

1.3

1.62

1.76

u/ml

0.77

5175

18409

Neurological diseases, wide definition

5838

15728

2.17

307.65

1.4

1.2

1.76

2.20

u/ml

1.12

1601

4277

Hypothyroidism, levothyroxine purchases

5510

14239

2.73

307.65

1.4

1.2

1.45

1.98

u/ml

2.52

1735

4290

Sciatica+with lumbago

7671

44389

1.80

307.65

1.3

1.41

1.85

u/ml

2.32

2277

12155

Pain in limb

13495

57926

1.76

307.65

1.3

1.53

1.78

u/ml

1.42

3477

15826

Other and unspecified iron deficiency

5609

28717

2.42

307.65

1.4

1.3

1.94

1.71

u/ml

0.61

1458

7583

Disease of hard tissues of teeth, NOS

8112

26573

1.78

307.65

1.3

1.2

1.72

1.84

u/ml

0.31

2167

7459

Symptoms and signs involving the digestive system and abdomen

17060

52782

1.82

307.65

1.3

1.56

1.92

u/ml

2.86

4591

14431

Persons encountering health services for examination and investigation

9869

32090

1.69

307.65

1.3

1.2

1.87

1.75

u/ml

0.33

2630

9244

Type 1 diabetes, wide definition, subgroup 1

5474

19266

4.76

307.65

2.0

1.3

2.13

1.88

u/ml

0.64

1720

5242

Sub-endpoint used in defining T1D endpoints

6084

25179

3.23

307.65

2.0

1.3

2.10

1.81

u/ml

0.87

1884

6767

Other special examinations and investigations of persons without complaint or reported diagnosis

10752

32090

1.90

307.65

1.4

1.2

1.62

1.75

u/ml

0.45

3022

9244

Disorders of thyroid, IBD co-morbidities

3191

10231

2.67

307.65

1.4

1.2

1.79

2.11

u/ml

0.59

871

2894

Anxiety (asthma-related co-morbidities)

11392

53440

1.94

307.65

1.4

1.3

1.39

1.76

u/ml

2.41

2839

15587

Other functional intestinal disorders

7948

36428

2.48

307.65

1.4

1.3

1.49

1.83

u/ml

1.56

2094

9664

Chronic gastritis

3680

18912

2.31

307.65

1.3

1.2

2.46

1.74

u/ml

1.10

659

4981

Persons encountering health services for other counselling and medical advice, not elsewhere classified

17792

68095

1.56

307.65

1.3

1.78

1.76

u/ml

0.06

4984

18393

Medical observation and evaluation for suspected diseases and conditions

11038

32090

2.00

307.65

1.3

1.2

1.76

1.75

u/ml

0.03

2712

9244

Type 1 diabetes, strict definition

2436

8166

6.44

307.65

2.3

1.3

2.52

1.90

u/ml

1.04

720

2174

Cystitis

13698

56733

1.58

307.65

1.3

1.54

1.66

u/ml

0.50

3827

15393

Other and unspecified anaemias

5580

30539

2.00

307.65

1.3

1.73

1.75

u/ml

0.03

1241

7776

Examination and observation for other reasons

11304

31934

2.47

307.65

1.4

1.2

2.17

1.74

u/ml

1.60

2674

9205

Functional dyspepsia

4557

23188

2.46

307.65

1.4

1.3

1.22

1.70

u/ml

2.73

1105

6472

Other diseases of liver

3104

14470

2.85

307.65

1.4

1.3

1.51

1.73

u/ml

0.36

694

3985

Diverticular disease of intestine

10551

36037

2.16

307.65

1.3

1.2

1.44

1.88

u/ml

2.72

2606

9869

Autoimmune diseases excluding thyroid diseases, strict definition

18744

58681

2.03

307.65

1.5

1.2

3.35

1.18

u/ml

41.54

5399

15364

Other anaemias

5628

30797

1.99

307.65

1.4

1.3

1.74

1.75

u/ml

0.01

1255

7849

Irritable bowel syndrome

6547

25219

3.93

307.65

1.4

1.3

0.93

1.76

u/ml

12.68

1733

7079

Benign neoplasm: Colon

7367

40226

2.03

307.65

1.3

1.2

1.56

1.73

u/ml

0.46

1741

10467

Intestinal infectious diseases

15069

80499

1.56

307.65

1.4

1.3

1.56

1.75

u/ml

1.02

3981

21962

Other intervertebral disc disorders

12217

50559

1.59

307.65

1.3

1.52

1.84

u/ml

1.97

3285

13847

Follow-up examination after treatment for conditions other than malignant neoplasms

6841

27440

1.86

307.65

1.3

1.2

2.18

1.66

u/ml

1.37

1400

7895

Low back pain

12864

57451

1.83

307.65

1.3

1.34

1.83

u/ml

4.89

3623

15664

Dermatitis and eczema

18941

76748

1.72

307.65

1.3

1.67

1.72

u/ml

0.18

5145

20872

Spondylopathies

10925

43829

1.63

307.65

1.3

1.2

1.32

1.91

u/ml

5.93

3168

11835

Disorders of the thyroid gland

15325

67474

1.65

307.65

1.4

1.3

1.50

1.68

u/ml

1.17

4457

18070

Nerve, nerve root and plexus disorders

15683

69947

1.49

307.65

1.3

1.57

1.67

u/ml

0.42

4338

19207

Other antidepressants

17506

55254

1.84

307.65

1.3

1.40

1.89

u/ml

5.24

4643

15404

Nutritional anaemias

7589

41658

2.06

307.65

1.4

1.3

1.99

1.67

u/ml

1.04

1915

10930

Mood disorders

17927

74363

1.77

307.65

1.4

1.3

1.39

1.74

u/ml

3.26

4513

20776

GASTRO-related operations

14242

46387

1.71

307.65

1.3

1.49

1.75

u/ml

1.66

3689

13607

Diabetes mellitus

16241

67530

1.54

307.65

1.5

1.2

1.77

1.69

u/ml

0.31

4672

18408

Diseases of liver

5584

28277

2.45

307.65

1.4

1.3

1.72

1.69

u/ml

0.04

1203

7677

Abnormalities of breathing

14959

58131

1.66

307.65

1.3

1.57

1.79

u/ml

1.09

4097

16174

Type1 diabetes, definitions combined, early onset

1942

7221

5.68

307.65

2.4

1.4

2.59

1.94

u/ml

0.90

545

1864

Insulin medication

9940

46002

2.15

307.65

1.7

1.2

1.91

1.82

u/ml

0.25

2954

12182

Type 1 diabetes, wide definition

5571

20201

4.41

307.65

2.0

1.3

2.15

1.86

u/ml

0.79

1747

5480

Diseases of the digestive system

7223

38336

2.24

307.65

1.7

1.2

7.63

1.15

u/ml

72.35

2380

9737

Dermatitis

9488

60401

1.78

307.65

1.4

1.3

1.61

1.67

u/ml

0.20

2686

16337

Insulin, fast-acting or short human

7372

31960

3.13

307.65

1.9

1.2

2.03

1.71

u/ml

1.15

2304

8453

Insomnia

14785

72678

1.67

307.65

1.3

1.25

1.73

u/ml

6.47

4323

19839

Constipation

15041

60318

2.01

307.65

1.3

1.28

1.80

u/ml

6.56

3785

16360

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

14760

60360

1.63

307.65

1.5

1.2

1.77

1.75

u/ml

0.06

4241

16346

Anaemias

5291

13253

3.56

307.65

1.4

1.2

1.77

1.94

u/ml

0.36

1437

3919

Hypothyroidism, strict autoimmune

12268

49233

1.87

307.65

1.4

1.2

1.47

1.13

u/ml

2.86

3676

12927

Sleep apnoea, including avohilmo

14535

64647

1.52

307.65

1.3

1.24

1.82

u/ml

9.81

4166

17539

Any mental disorder

16946

61891

1.48

307.65

1.3

1.63

1.78

u/ml

0.70

4330

17416

Depression medications

6086

15217

2.41

307.65

1.4

1.2

1.39

1.93

u/ml

2.42

1706

4572

Asthma, including avohilmo

18614

77188

1.47

307.65

1.3

1.51

1.77

u/ml

1.90

5178

20836

Sleep disorders (combined)

18811

66635

1.65

307.65

1.3

1.27

1.87

u/ml

9.96

5191

17862

Insulin, combination of fast acting with intermediate-acting or long-acting

9945

49673

2.17

307.65

1.7

1.2

1.91

1.77

u/ml

0.45

2955

13008

Abdominal and pelvic pain

17047

52775

1.82

307.65

1.3

1.63

1.92

u/ml

1.85

4612

14430

Other diseases of urinary system

15328

62523

1.50

307.65

1.3

1.60

1.70

u/ml

0.42

4082

17052

Nonalcoholic fatty liver disease

1866

7694

3.61

307.65

1.4

1.3

1.20

1.89

u/ml

2.76

408

2145

Gastrointestinal diseases

11185

30952

2.09

307.65

1.4

1.2

2.00

1.31

u/ml

5.17

3119

8642

Any gastric operation

14242

46387

1.71

307.65

1.3

1.49

1.75

u/ml

1.66

3689

13607

ILD medications: prednisolone, methylprednisolone, prednisone

17166

69532

1.50

307.65

1.3

1.38

1.79

u/ml

4.58

4574

19195

Other dorsopathies, not elsewhere classified

17014

60141

1.64

307.65

1.3

1.46

1.85

u/ml

3.42

4808

16300

Recurrent or chronic depression

7698

27063

2.45

307.65

1.4

1.2

1.24

2.06

u/ml

8.07

2049

7805

Insulin, intermediate and long-acting

9352

45681

2.45

307.65

1.7

1.2

1.96

1.76

u/ml

0.71

2762

11920

Asthma

12759

44926

1.65

307.65

1.3

1.47

1.82

u/ml

2.23

3541

12703

Other noninfective gastroenteritis and colitis

4408

22376

2.51

307.65

1.5

1.3

1.37

1.86

u/ml

2.05

1103

5905

Used for control exclusion in common control thyroid runs

19536

56795

2.01

307.65

1.5

1.2

2.65

1.17

u/ml

27.70

5662

14871

Shoulder lesions

10728

43476

1.64

307.65

1.3

1.2

1.47

1.81

u/ml

2.13

3100

11983

Hypothyroidism and >3 levothyroxin purchases

5510

14239

2.73

307.65

1.4

1.2

1.45

1.98

u/ml

2.52

1735

4290

Episodal and paroxysmal disorders

18277

64892

1.57

307.65

1.3

1.30

1.87

u/ml

8.71

5011

17511

Pain (limb, back, neck, head abdominally)

11736

35840

1.82

307.65

1.3

1.71

2.05

u/ml

1.70

3160

9779

Asthma (only as main-diagnosis)

11560

44926

1.65

307.65

1.3

1.45

1.82

u/ml

2.46

3263

12703

Symptoms and signs involving the circulatory and respiratory systems

17408

58379

1.66

307.65

1.3

1.55

1.80

u/ml

1.55

4777

16255

Type 1 diabetes, definitions combined

2788

9658

5.56

307.65

2.2

1.3

2.38

1.90

u/ml

0.82

819

2554

Dorsopathies

16863

60716

1.54

307.65

1.3

1.38

1.87

u/ml

5.57

4781

16391

Mood [affective] disorders

17905

74330

1.77

307.65

1.4

1.3

1.40

1.74

u/ml

3.19

4505

20775

Diseases of the skin and subcutaneous tissue

16249

56668

1.57

307.65

1.3

1.77

1.69

u/ml

0.31

4336

15683

General examination and investigation of persons without complaint and reported diagnosis

9899

32076

1.79

307.65

1.3

1.2

1.48

1.75

u/ml

1.39

3397

9243

Type 1 diabetes, strict definition, subgroup 1

2353

7755

6.78

307.65

2.3

1.3

2.48

1.93

u/ml

0.85

700

2081

Diseases of oesophagus, stomach and duodenum

18622

67032

1.91

307.65

1.4

1.3

1.76

1.64

u/ml

0.54

4663

18922

Headache

12191

58129

1.95

307.65

1.4

1.3

1.38

1.76

u/ml

2.69

3299

15991

Depression or dysthymia

11346

34781

2.08

307.65

1.3

1.43

2.04

u/ml

4.65

3021

9614

Benign neoplasm of colon, rectum, anus and anal canal

8866

44429

2.00

307.65

1.3

1.2

1.65

1.70

u/ml

0.11

2085

11706

Noninfective enteritis and colitis

8148

46719

2.09

307.65

1.4

1.3

1.32

1.76

u/ml

3.12

2073

12739

Other headache syndromes

7216

43264

1.96

307.65

1.3

1.25

1.74

u/ml

3.23

1971

11946

Intestinal infectious diseases

19783

72858

1.75

307.65

1.4

1.3

1.54

1.76

u/ml

1.58

5391

19657

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

6367

17845

2.02

307.65

1.3

1.37

2.14

u/ml

4.71

1737

5131

Soft tissue disorders

17094

61074

1.58

307.65

1.3

1.49

1.82

u/ml

2.73

4711

16680

Pain in throat and chest

14061

54847

1.72

307.65

1.3

1.59

1.79

u/ml

0.96

3661

15305

Other diseases of intestines

20023

65873

2.02

307.65

1.3

1.46

1.84

u/ml

4.06

5391

18323

Collagenous colitis

1775

6994

3.90

307.65

1.4

1.3

1.34

1.68

u/ml

0.60

464

1853

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

15689

71984

1.68

307.65

1.4

1.3

1.85

1.65

u/ml

0.97

3957

19828

Diabetes medication

16246

68757

1.53

307.65

1.5

1.2

1.78

1.69

u/ml

0.35

4648

18735

Codeine or tramadol medication

18024

70177

1.54

307.65

1.3

1.49

1.72

u/ml

1.59

4771

19585

Autoimmune diseases excluding thyroid diseases

19301

60254

2.03

307.65

1.5

1.2

3.32

1.18

u/ml

42.67

5556

15759

Other specific joint derangements/joint disorders

12997

54415

1.75

307.65

1.4

1.3

1.57

1.79

u/ml

0.98

3460

14956

Anxiety disorders, excluding more controls

14498

58941

1.83

307.65

1.4

1.3

1.46

1.76

u/ml

1.93

3718

16769

Asthma, excluding more controls

12483

43452

1.66

307.65

1.3

1.48

1.81

u/ml

1.99

3472

12311

Malaise and fatigue

7580

37790

1.82

307.65

1.4

1.3

1.32

1.77

u/ml

2.88

1876

9952

Oral corticosteroids

16388

69566

1.52

307.65

1.3

1.35

1.77

u/ml

4.86

4496

19140

General symptoms and signs

18249

61756

1.64

307.65

1.3

1.50

1.81

u/ml

2.65

5038

17016

Autoimmune diseases related-to ILD

13910

78372

1.71

307.65

1.3

1.52

1.71

u/ml

1.03

3672

21544

Autoimmune diseases

20720

60821

2.01

307.65

1.5

1.2

2.75

1.19

u/ml

30.95

6063

15884

Codeine

15487

57703

1.61

307.65

1.3

1.36

1.74

u/ml

3.49

4115

16327

Atopic dermatitis

10036

56661

1.63

307.65

1.4

1.3

1.60

1.69

u/ml

0.27

2606

15884

Type 1 diabetes

6009

22866

3.95

307.65

2.0

1.3

2.10

1.82

u/ml

0.78

1856

6214

Spondylosis

7278

36130

1.85

307.65

1.3

1.2

1.25

1.93

u/ml

6.17

2168

9551

Depression

17053

72734

1.82

307.65

1.4

1.3

1.37

1.75

u/ml

3.59

4283

20405

Diaphragmatic hernia

4967

28804

2.01

307.65

1.3

1.2

1.60

1.67

u/ml

0.13

1136

7527

Diseases of the eye and adnexa

13431

48516

1.50

301.53

1.4

1.3

1.79

1.73

u/ml

0.19

3758

13551

Dyspnoea

12946

69438

1.50

300.61

1.3

1.43

1.71

u/ml

1.70

3413

18867

Nausea and vomiting

4065

22543

2.06

300.47

1.4

1.3

1.38

1.87

u/ml

1.77

1063

5821

Metabolic disorders

13550

60144

1.49

298.58

1.3

1.74

u/ml

0.00

3492

16794

Abnormalities of heart beat

5272

31471

1.87

298.24

1.3

1.41

1.80

u/ml

1.64

1404

8501

Other joint disorders

14412

55716

1.48

297.50

1.3

1.38

1.82

u/ml

4.41

4045

15258

Asthma, unspecified (mode), excluding more controls

7949

39502

1.67

296.96

1.3

1.44

1.77

u/ml

1.54

2091

11140

Symptoms and signs concerning food and fluid intake

1852

8030

3.10

296.66

1.4

1.3

1.46

1.93

u/ml

0.95

465

2022

Symptoms and signs involving cognition, perception, emotional state and behaviour

14263

71720

1.47

295.98

1.3

1.58

1.70

u/ml

0.48

3676

19803

Acute upper respiratory infections

15822

72874

1.44

295.70

1.3

1.53

1.72

u/ml

1.05

4243

19676

Cough

6052

36198

1.79

293.59

1.3

1.75

1.88

u/ml

0.24

1516

9645

Other diseases of upper respiratory tract

16607

64896

1.43

293.17

1.3

1.59

1.77

u/ml

0.89

4207

17839

Myalgia

3864

21934

2.11

292.21

1.4

1.3

1.26

1.87

u/ml

3.15

878

6112

Other disorders of urethra and urinary system

10510

53492

1.56

289.23

1.3

1.64

u/ml

0.01

2682

14495

Other retinal disorders

8180

42784

1.64

288.83

1.5

1.2

1.97

1.66

u/ml

1.06

2263

10981

Chronic rhinitis, nasopharyngitis and pharyngitis

5034

30814

1.91

288.43

1.3

1.60

1.72

u/ml

0.22

1226

8683

Asthma, unspecified (mode)

8082

40819

1.65

287.79

1.3

1.43

1.79

u/ml

1.76

2119

11476

Mycoses

12891

82406

1.48

287.37

1.3

1.60

1.70

u/ml

0.37

3391

22615

Polyneuropathies and other disorders of the peripheral nervous system

2874

14820

2.33

286.33

1.4

1.2

1.43

1.92

u/ml

1.45

649

3794

Haemorrhoids and perianal venous thrombosis

4078

23247

1.99

285.54

1.3

1.2

1.53

1.79

u/ml

0.65

1116

6264

Certain infectious and parasitic diseases

11517

40820

1.53

283.26

1.3

1.73

1.81

u/ml

0.23

3080

11365

Pain, not elsewhere classified

4370

25873

1.97

280.65

1.4

1.3

1.29

1.85

u/ml

2.73

1235

7090

Benzodiazepine use

14982

77310

1.44

280.43

1.3

1.37

1.70

u/ml

2.57

3778

21527

Disorders of eyelid, lacrimal system and orbit

12215

67666

1.49

277.11

1.3

1.49

1.67

u/ml

0.87

3205

18304

Hypothyroidism, drug reimbursement

2419

8139

2.54

276.64

1.4

1.2

1.74

1.80

u/ml

0.06

663

2470

Infections, IBD-co-morbidities

2244

7369

2.55

273.17

1.4

1.2

1.83

2.34

u/ml

0.72

551

2007

Personality disorders, excluding more controls

4371

26198

1.97

273.08

1.4

1.3

1.47

1.66

u/ml

0.43

1060

7962

Asthma (diagnoses ohter than nonallergic)

13169

81073

1.46

272.86

1.3

1.49

1.72

u/ml

1.37

3526

21898

Other/unspecified dorsalgia

5458

34032

1.80

271.72

1.3

1.55

1.83

u/ml

0.76

1393

9210

Dysphagia

3234

17547

2.14

271.32

1.4

1.2

1.31

1.81

u/ml

1.47

802

4612

Rotator cuff syndrome

7910

38221

1.62

269.43

1.3

1.2

1.43

1.84

u/ml

2.44

2372

10372

Other gastritis (incl. Duodenitis)

2973

15798

2.21

267.77

1.4

1.2

1.79

1.83

u/ml

0.05

756

4233

Symptoms and signs involving the nervous and musculoskeletal systems

8228

56826

1.61

267.19

1.3

1.33

1.72

u/ml

2.54

2529

14929

Disorders of gallbladder, biliary tract and pancreas

13817

64819

1.45

266.01

1.3

1.38

1.72

u/ml

2.85

3779

17750

Dizziness and giddiness

10542

59982

1.52

263.95

1.3

1.57

1.70

u/ml

0.40

2727

16346

Other diseases of anus and rectum

3814

21905

1.98

261.11

1.3

1.2

1.19

1.83

u/ml

4.60

953

5879

Other systemic involvement of connective tissue (FG)

3843

22114

2.01

260.98

1.4

1.3

1.58

1.75

u/ml

0.37

1070

5853

Other disorders of lacrimal gland

5115

32238

1.83

260.46

1.4

1.3

1.42

1.72

u/ml

0.96

1418

8652

Diseases of oral cavity, salivary glands and jaws

7963

27330

1.62

260.32

1.3

1.2

1.80

1.86

u/ml

0.11

2031

7601

Pain and other conditions associated with female genital organs and menstrual cycle

3864

21018

2.08

259.30

1.4

1.3

1.45

1.68

u/ml

0.51

984

5799

Migraine, single triptan purchase ok & required. ICD-code if available is included

12529

62953

1.48

259.15

1.3

1.29

1.73

u/ml

3.97

3591

17383

Triptan medication for migraine, single purchase ok

12529

62953

1.48

259.15

1.3

1.29

1.73

u/ml

3.97

3591

17383

Lumbar disc prolapse

8829

47319

1.56

254.42

1.3

1.56

1.85

u/ml

1.30

2488

12967

Certain infectious and parasitic diseases

15448

58664

1.41

251.15

1.3

1.78

1.71

u/ml

0.24

3973

16531

Noninfectious colitis NAS

2272

11476

2.53

250.54

1.5

1.3

1.39

1.83

u/ml

1.05

587

3076

Persons encountering health services in other circumstances

6203

40969

1.70

247.57

1.4

1.3

1.44

1.75

u/ml

1.22

1698

11000

Disorders of lacrimal system

6096

40279

1.71

246.76

1.4

1.3

1.47

1.68

u/ml

0.64

1688

10759

Diabetic retinopathy, strict definition

2586

12141

2.42

246.34

1.8

1.3

2.09

1.59

u/ml

1.06

798

3418

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

865

2897

5.43

245.53

1.8

1.2

2.42

1.73

u/ml

0.52

270

890

Budesonide

2365

12198

2.46

245.44

1.4

1.3

1.65

1.80

u/ml

0.19

570

3366

Special screening examination for infectious and parasitic diseases

4285

18949

1.91

245.31

1.3

1.2

1.47

1.71

u/ml

0.60

755

5813

Inflammatory bowel disease

4844

30619

1.83

243.62

1.3

1.26

1.69

u/ml

2.21

1258

8594

Temporomandibular joint disorders, including avohilmo

7530

51888

1.63

241.26

1.4

1.3

1.09

1.64

u/ml

5.82

2110

14544

Symptoms and signs involving the skin and subcutaneous tissue

10138

72356

1.50

241.08

1.3

1.35

1.70

u/ml

2.66

2574

19746

Antihypertensive medication - note that there are other indications

10964

42366

1.50

239.84

1.4

1.3

1.58

1.83

u/ml

1.12

3192

11735

Coxibs

3994

12097

1.94

238.68

1.3

1.42

2.16

u/ml

2.77

1070

3130

Other nutritional deficiencies

10029

68976

1.50

238.35

1.3

1.51

1.64

u/ml

0.48

2757

19091

Exposure to unspecified factor

14897

82396

1.40

236.65

1.3

1.90

1.68

u/ml

0.91

3301

23096

Arthropathies

14548

55938

1.41

236.16

1.3

1.40

1.82

u/ml

3.95

4092

15297

Fibromyalgia

1725

8117

2.92

235.75

1.4

1.2

1.23

1.49

u/ml

0.39

473

2272

Abnormal findings on examination of blood, without diagnosis

5645

33795

1.70

234.10

1.4

1.3

2.16

1.78

u/ml

1.07

1469

8840

Disorders of choroid and retina

10281

53083

1.48

232.72

1.4

1.2

2.03

1.71

u/ml

1.21

2795

14053

Spinal stenosis

5811

28721

1.68

231.23

1.3

1.2

1.28

1.98

u/ml

4.52

1592

7280

17048

68561

1.37

230.05

1.3

1.56

1.73

u/ml

0.88

4566

18569

Disturbances of skin sensation

4389

27586

1.86

229.72

1.4

1.3

1.02

1.75

u/ml

8.23

1105

7854

Acute upper respiratory infections of multiple and unspecified sites

11476

63332

1.45

228.86

1.4

1.3

1.56

1.72

u/ml

0.66

3097

17372

Other pulmonary diagnosis

12203

45340

1.45

228.76

1.3

1.53

1.82

u/ml

1.48

3257

12843

Other arthrosis

6727

31354

1.63

228.62

1.3

1.2

1.57

1.85

u/ml

0.92

1744

8527

Systemic connective tissue disorders

4931

31709

1.77

228.54

1.4

1.3

1.46

1.68

u/ml

0.63

1325

8380

Asthma-related infections

8529

59664

1.53

228.42

1.4

1.3

1.51

1.74

u/ml

0.86

2242

15943

Asthma, hospital admission 2, infections

8529

59664

1.53

228.42

1.4

1.3

1.51

1.74

u/ml

0.86

2242

15943

Disorders of conjunctiva

12769

77841

1.43

228.31

1.3

1.64

1.68

u/ml

0.11

3295

21386

Weight loss

1624

7537

2.90

225.85

1.4

1.3

1.47

1.76

u/ml

0.42

409

1871

Excluding asthma or asthma-COPD overlap

12170

45340

1.44

224.12

1.3

1.57

1.82

u/ml

1.19

3256

12843

Dental operations

8057

28565

1.56

223.24

1.3

1.2

1.87

1.78

u/ml

0.20

2104

7725

Migraine with aura

4364

27670

1.86

223.12

1.3

1.07

1.75

u/ml

4.89

1194

7786

Disorders of synovium and tendon

7554

46296

1.57

222.11

1.3

1.76

1.72

u/ml

0.08

2106

12794

Asthma, hospital admissions , main diagnosis only

12209

81626

1.42

221.45

1.3

1.49

1.73

u/ml

1.37

3396

22062

6765

46395

1.61

221.16

1.4

1.3

1.47

1.79

u/ml

1.30

1791

12506

Genitourinary diseases

8582

30150

1.54

221.01

1.3

1.67

2.10

u/ml

2.04

2265

8284

Abnormal weight loss

1481

6704

3.00

218.80

1.4

1.3

1.55

1.75

u/ml

0.24

369

1661

ILD differential diagnosis

12097

45202

1.44

218.41

1.3

1.54

1.82

u/ml

1.40

3240

12779

Non-selective monoamine reuptake inhibitors

4855

30021

1.74

218.22

1.3

1.2

1.31

1.83

u/ml

2.67

1244

8115

COPD differential diagnosis

12097

45220

1.44

217.86

1.3

1.54

1.82

u/ml

1.40

3240

12784

Other disorders of skin and subcutaneous tissue

9196

59383

1.49

217.57

1.3

1.55

1.67

u/ml

0.49

2398

15878

Caries of enamel

13407

74280

1.40

217.29

1.3

1.55

1.72

u/ml

0.77

3338

20810

Other symptoms and signs involving the digestive system and abdomen

2523

13715

2.21

217.20

1.4

1.2

1.24

1.67

u/ml

1.22

722

3648

Chronic lower respiratory diseases

18153

76625

1.34

213.97

1.3

1.54

1.76

u/ml

1.46

4965

20836

Chronic sinusitis

6107

41538

1.63

213.69

1.3

1.50

1.67

u/ml

0.43

1523

11841

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

7094

48168

1.57

212.93

1.3

1.60

1.75

u/ml

0.40

1857

13602

Other systemic involvement of connective tissue

3910

24290

1.86

210.84

1.4

1.3

1.57

1.63

u/ml

0.12

1088

6438

Disorders of lipoprotein metabolism and other lipidaemias

10367

47258

1.45

209.91

1.3

1.2

1.76

1.73

u/ml

0.06

2535

13037

Obesity related asthma

4777

31087

1.74

209.49

1.3

1.26

1.79

u/ml

3.39

1347

8460

Factors influencing health status and contact with health services

4131

12379

1.82

208.98

1.3

1.2

1.93

1.92

u/ml

0.02

1092

3615

Cholelithiasis

11352

58759

1.43

208.64

1.3

1.33

1.67

u/ml

2.78

3126

16013

Osteoporosis with pathological fracture (FG)

1124

4575

3.39

207.54

1.4

1.2

1.18

1.71

u/ml

1.13

333

1066

Disorders of other endocrine glands

6504

44533

1.60

205.80

1.4

1.3

1.49

1.74

u/ml

0.86

1756

11817

Fibrosis and cirrhosis of liver

1183

4957

3.26

205.68

1.4

1.3

1.70

1.44

u/ml

0.29

255

1323

Cardiac arrhythmias

9121

43167

1.49

204.57

1.3

1.2

1.50

1.71

u/ml

0.92

2535

11954

Nonorganic sleeping disorders, excluding more controls

3110

18392

2.01

204.44

1.4

1.3

1.61

1.67

u/ml

0.08

764

5391

Conjunctivitis

11735

74825

1.42

204.37

1.3

1.62

1.66

u/ml

0.14

3014

20611

Excessive, frequent and irregular menstruation

6612

24960

1.64

204.13

1.3

1.32

1.72

u/ml

1.95

1814

6718

Gingivitis and periodontal diseases

14709

58841

1.37

203.70

1.3

1.55

1.78

u/ml

1.36

3848

16242

Cholecystectomy

9456

60199

1.46

202.63

1.3

1.25

1.67

u/ml

3.82

2613

16260

Cholelithiasis, broad definition with cholecystitis

11702

59627

1.41

202.18

1.3

1.32

1.68

u/ml

3.07

3217

16233

Cardiovascular diseases

10839

43589

1.45

202.15

1.3

1.57

1.80

u/ml

1.04

3095

12315

Viral infections characterized by skin and mucous membrane lesions

12583

82948

1.39

200.78

1.3

1.63

1.70

u/ml

0.21

3434

22453

Complications of surgical and medical care, not elsewhere classified

13932

74137

1.37

200.64

1.3

1.55

1.67

u/ml

0.54

3645

20381

Type 2 diabetes

13738

61989

1.38

200.37

1.4

1.2

1.64

1.69

u/ml

0.14

3926

17032

Dental pulpitis, including avohilmo

13975

70656

1.38

199.96

1.3

1.46

1.72

u/ml

1.80

4042

19616

Candidiasis

4399

28618

1.78

198.87

1.4

1.3

1.70

1.62

u/ml

0.13

1121

7765

Type 2 diabetes, wide definition

9987

47309

1.45

197.43

1.4

1.2

1.79

1.77

u/ml

0.03

2759

12711

Polyarthropathies

9364

44976

1.46

194.65

1.3

1.44

1.80

u/ml

1.89

2499

12385

Hernia of abdominal wall, postoperative

2309

12486

2.13

194.18

1.3

1.2

1.53

1.86

u/ml

0.54

571

3689

Other bacterial intestinal infections

3129

18662

1.93

193.97

1.4

1.3

1.64

1.74

u/ml

0.14

753

4986

Dental caries

3227

18503

1.89

193.49

1.4

1.3

1.71

1.93

u/ml

0.43

744

5265

Fever of other and unknown origin

7711

49339

1.51

193.13

1.3

1.54

1.81

u/ml

1.10

2080

13267

Hyperkinetic disorders, excluding more controls

2371

12824

2.26

191.24

1.5

1.4

1.87

1.75

u/ml

0.13

544

3696

Bronchitis

15759

78674

1.34

190.94

1.3

1.52

1.72

u/ml

1.17

4213

21410

Missing teeth due to accident, extraction or parodontitis

7247

48868

1.52

189.33

1.3

1.48

1.72

u/ml

1.10

1777

12859

Dental caries, including avohilmo

10030

37965

1.44

188.66

1.3

1.76

1.78

u/ml

0.06

2672

10118

Diseases of pulp and periapical tissues, including avohilmo

15822

64830

1.34

188.44

1.3

1.69

1.70

u/ml

0.04

4234

17495

Finngen Rheumatological endpoints

14342

63883

1.36

188.09

1.3

1.43

1.72

u/ml

2.16

4084

17664

Pure hypercholesterolaemia

8939

42750

1.46

187.62

1.3

1.2

1.78

1.74

u/ml

0.10

2035

11693

Other reaction to severe stress, and adjustment disorders

5838

40690

1.61

185.90

1.4

1.3

1.28

1.67

u/ml

2.02

1544

11940

Vasomotor and allergic rhinitis

6019

41367

1.60

185.42

1.4

1.3

1.49

1.77

u/ml

0.99

1687

11747

Complications of procedures, not elsewhere classified

11171

70769

1.40

185.41

1.3

1.50

1.67

u/ml

0.84

2938

19466

Diseases of the ear and mastoid process

17474

70305

1.32

184.65

1.3

1.73

1.67

u/ml

0.22

4603

19604

Implicit Sepsis

10948

60941

1.40

183.92

1.3

1.71

u/ml

0.00

2709

16485

Somatoform disorder

2560

14828

2.08

183.38

1.4

1.3

1.55

1.60

u/ml

0.06

662

4196

Implicit Sepsis

9725

54958

1.43

183.23

1.3

1.74

1.72

u/ml

0.04

2362

14735

Oedema, not elsewhere classified

4076

25839

1.73

182.84

1.4

1.2

1.49

1.85

u/ml

1.23

985

6831

Caries of dentine

2853

16300

1.93

181.76

1.4

1.3

1.69

1.92

u/ml

0.45

668

4601

Menorrhagia

5318

19878

1.67

181.65

1.3

1.31

1.69

u/ml

1.49

1442

5392

Falls/tendency to fall

16569

66248

1.32

180.89

1.3

1.81

1.66

u/ml

0.64

4256

18834

Diseases of pulp and periapical tissues and dental caries

9008

33795

1.46

180.33

1.3

1.82

1.79

u/ml

0.07

2358

8987

Care involving use of rehabilitation procedures

8844

60583

1.45

180.05

1.3

1.64

1.74

u/ml

0.30

2089

16690

Migraine without aura

3631

23279

1.85

179.09

1.4

1.3

1.41

1.73

u/ml

0.98

1058

6618

Other arrhythmias

8940

50182

1.45

178.63

1.3

1.43

1.68

u/ml

1.13

2335

13793

Other diseases of lip and oral mucosa

5501

38123

1.61

178.35

1.3

1.45

1.69

u/ml

0.91

1345

10318

Generalized anxiety disorder

2905

17678

2.00

178.15

1.4

1.3

1.28

1.64

u/ml

1.03

689

5135

Second line medication for Crohn's disease

8142

60300

1.47

177.57

1.3

1.22

1.73

u/ml

5.15

2138

16416

Acetic acid derivatives and related substances

3703

11722

1.80

177.44

1.3

1.70

2.14

u/ml

0.87

976

3042

Benign neoplasms

14475

62946

1.34

176.95

1.3

1.54

1.78

u/ml

1.30

3988

17679

Caries of dentine, including avohilmo

10903

42175

1.40

176.89

1.3

1.78

1.74

u/ml

0.10

2893

11242

Disorders of skin appendages

7223

52605

1.51

176.37

1.4

1.3

1.61

1.66

u/ml

0.13

1987

14491

Condition for Implicit Sepsis (Organ dysfunction codes)

12534

67375

1.36

175.80

1.3

1.59

1.72

u/ml

0.48

3216

18441

Use of hypnotics and sedatives

14725

66949

1.34

175.72

1.3

1.34

1.77

u/ml

4.76

3796

18742

Personality disorders

4371

29214

1.72

175.27

1.4

1.3

1.47

1.60

u/ml

0.27

1060

8447

Implicit viral Sepsis

3749

23961

1.76

174.74

1.4

1.3

1.98

1.81

u/ml

0.24

917

6259

Visual disturbances and blindness

7021

50876

1.51

174.15

1.3

2.02

1.68

u/ml

0.88

1654

13528

Disorders of adult personality and behaviour

4636

31413

1.69

173.85

1.4

1.3

1.57

1.61

u/ml

0.07

1110

9053

Cervical disc disorders

4353

28680

1.67

173.68

1.3

1.2

1.32

1.99

u/ml

3.37

1199

7551

Vocal cord dysfunction

1920

9058

2.21

173.66

1.3

1.2

1.70

1.80

u/ml

0.11

489

2595

Concussion

7307

43173

1.49

173.61

1.3

1.81

1.87

u/ml

0.13

1961

11752

Disorders of vitreous body

5990

40774

1.56

172.46

1.3

1.2

1.69

1.65

u/ml

0.07

1611

10557

Disorders of vitreous body and globe

6129

41647

1.55

172.25

1.3

1.2

1.69

1.65

u/ml

0.09

1636

10794

Cervicalgia

2804

16760

1.92

171.99

1.3

1.05

1.93

u/ml

7.57

767

4456

Heartburn

1614

8166

2.42

171.98

1.4

1.2

1.11

1.85

u/ml

2.85

404

2251

Hypertensive diseases (excluding secondary)

7818

33098

1.49

171.54

1.3

1.59

1.72

u/ml

0.41

2294

9447

Chronic diseases of tonsils and adenoids

11835

58123

1.38

170.63

1.3

1.66

1.76

u/ml

0.31

3023

16234

IBD patients in KELA-register

3442

21871

1.82

169.93

1.3

1.32

1.81

u/ml

1.72

874

6254

KRA_PSY_EATING, excluding more controls

1804

9769

2.46

169.76

1.6

1.3

1.01

1.57

u/ml

2.90

471

2905

Carpal tunnel syndrome

8064

52665

1.46

169.50

1.3

1.2

1.55

1.68

u/ml

0.41

2328

14317

Other enthesopathies

3971

25899

1.72

169.26

1.3

1.2

1.65

1.81

u/ml

0.30

1084

7141

Oxicams

2790

9102

1.92

168.05

1.3

1.2

1.32

2.08

u/ml

2.58

903

2392

Statin medication

9964

42417

1.41

167.20

1.4

1.3

1.65

1.79

u/ml

0.50

2802

12286

Irregular menses

8059

47654

1.48

166.91

1.4

1.3

1.26

1.53

u/ml

1.39

2290

13483

Rheumatism, unspecified

2009

11102

2.19

166.70

1.4

1.2

1.41

1.70

u/ml

0.46

576

2962

Other symptoms and signs involving the nervous and musculoskeletal systems

5781

40912

1.56

165.92

1.4

1.3

1.27

1.70

u/ml

2.58

2014

10962

Ulcerative colitis

3515

22534

1.78

165.43

1.3

1.38

1.80

u/ml

1.37

895

6385

Visual disturbances

6558

47446

1.52

165.41

1.3

1.95

1.67

u/ml

0.64

1557

12656

Endometriosis

5438

22064

1.62

165.28

1.3

1.30

1.64

u/ml

1.62

1462

6031

Inflammatory diseases of female pelvic organs

9812

55454

1.42

164.99

1.3

1.40

1.50

u/ml

0.36

2562

15429

Faecal incontinence

1331

6393

2.63

164.71

1.4

1.2

1.47

1.66

u/ml

0.22

306

1649

Other diseases of intestine

1695

8761

2.27

164.47

1.3

1.2

2.00

2.18

u/ml

0.21

359

2351

Provisional assignment of new diseases of uncertain etiology

7427

54807

1.47

163.76

1.3

1.55

1.66

u/ml

0.36

2093

14896

Hypertension, essential

10491

45412

1.39

163.63

1.3

1.77

1.72

u/ml

0.14

3015

12843

Noninflammatory disorders of female genital tract

7047

25580

1.53

162.98

1.4

1.3

1.58

1.73

u/ml

0.39

1948

6862

Codes for special purposes

7429

54879

1.47

162.70

1.3

1.55

1.66

u/ml

0.36

2093

14909

Cervicobrachial syndrome

3035

18802

1.84

162.69

1.3

1.2

1.33

1.92

u/ml

2.33

968

5151

Pain in thoracic spine

2234

12806

2.06

162.00

1.4

1.3

1.10

1.94

u/ml

3.18

676

3454

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

1744

9195

2.24

161.82

1.4

1.2

2.41

2.05

u/ml

0.40

342

2441

Acute sinusitis

7741

53333

1.46

161.79

1.4

1.3

1.68

1.66

u/ml

0.04

2174

14895

COPD/asthma related infections

15411

61915

1.32

161.65

1.3

1.58

1.74

u/ml

0.78

4105

16993

COPD/asthma/ILD related infections

15411

61915

1.32

161.65

1.3

1.58

1.74

u/ml

0.78

4105

16993

Symptoms and signs involving speech and voice

4340

29256

1.66

160.87

1.3

1.49

1.68

u/ml

0.49

1060

7875

Complications of medical and surgical care

9774

69038

1.39

160.45

1.3

1.54

1.65

u/ml

0.35

2322

18990

Intestinal malabsorption

838

3422

3.64

159.48

1.6

1.2

3.04

1.20

u/ml

2.18

253

897

Other external causes of accidental injury

12376

48501

1.35

158.47

1.3

1.83

1.60

u/ml

0.96

3155

14201

Pruritus

1684

8990

2.33

157.54

1.4

1.3

1.35

1.67

u/ml

0.55

417

2390

Syncope and collapse

5638

33941

1.54

157.53

1.3

1.66

1.75

u/ml

0.20

1430

8796

Other disorders of fluid, electrolyte and acid-base balance

3621

22273

1.71

157.08

1.4

1.2

1.81

1.79

u/ml

0.03

932

5774

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

1180

3674

2.61

156.00

1.3

1.2

1.26

2.81

u/ml

3.84

288

909

Chronic apical periodontitis

16172

74813

1.30

155.59

1.3

1.68

1.67

u/ml

0.05

4366

20624

Fall on same level

16933

75426

1.29

154.64

1.3

1.86

1.69

u/ml

0.72

4144

21219

Inflammatory bowel disease, strict (require KELA)

3442

22372

1.77

154.47

1.3

1.32

1.78

u/ml

1.58

874

6339

Haemorrhage from respiratory passages

3854

22705

1.67

154.35

1.3

1.89

1.96

u/ml

0.10

972

5845

Specific personality disorders

3786

25236

1.73

154.31

1.4

1.3

1.51

1.57

u/ml

0.10

923

7277

5-aminosalicylic acid

3125

19809

1.81

154.28

1.3

1.35

1.84

u/ml

1.46

768

5601

Triptan medication for migraine, min. 3 purchases

9254

54386

1.42

153.84

1.3

1.37

1.59

u/ml

0.99

2699

15367

Excessive attrition of teeth

8142

61722

1.43

153.37

1.3

1.51

1.67

u/ml

0.57

2227

17167

Benign neoplasm: Colon, unspecified

2841

17503

1.83

153.27

1.3

1.2

1.84

1.85

u/ml

0.02

613

4476

Viral and other specified intestinal infections

4638

30964

1.63

153.24

1.5

1.3

1.69

1.77

u/ml

0.16

1316

8383

Any death

3707

39930

0.62

152.39

1.2

1.3

2.08

1.75

u/ml

0.56

809

10111

Obesity and other hyperalimentation

9071

67216

1.40

152.05

1.3

1.51

1.62

u/ml

0.38

2458

18722

Obesity

9031

67014

1.40

151.45

1.3

1.52

1.62

u/ml

0.35

2447

18666

Accidents

12314

48501

1.35

151.43

1.3

1.87

1.60

u/ml

1.20

3149

14201

Voice disturbances

3590

23628

1.73

151.14

1.3

1.51

1.64

u/ml

0.25

887

6376

Urticaria and erythema

5435

38849

1.56

150.88

1.4

1.3

1.67

1.75

u/ml

0.18

1469

10677

Symptoms and signs involving the urinary system

9603

56265

1.38

150.51

1.3

1.56

1.74

u/ml

0.83

2315

15068

Other symptoms and signs involving cognitive functions and awareness

5276

33714

1.54

150.45

1.3

1.2

1.65

1.74

u/ml

0.17

1230

8710

Other specified/unspecified arthritis

3612

23702

1.71

150.40

1.3

1.34

1.88

u/ml

2.12

1000

6395

Polyuria

2634

16024

1.86

149.42

1.3

1.2

1.79

1.85

u/ml

0.08

568

4214

Atopic dermatitis, strict definition with reimbursement

5023

34318

1.59

148.89

1.4

1.3

1.97

1.71

u/ml

0.57

1322

9619

Diabetic retinopathy, excluding more controls

3515

12736

1.79

148.47

1.7

1.3

1.88

1.55

u/ml

0.75

1031

3385

Persons encountering health services for specific procedures and health care

15634

76303

1.29

148.37

1.3

1.71

1.72

u/ml

0.03

3837

21316

Ovarian cyst

5632

23139

1.56

145.78

1.3

1.39

1.64

u/ml

0.74

1551

6318

Diseases of the respiratory system

9674

37120

1.39

145.60

1.3

1.54

1.84

u/ml

1.33

2586

10347

Fissure and fistula of anal and rectal regions

2951

18570

1.77

144.95

1.3

1.2

1.23

1.85

u/ml

2.58

768

5215

L04AX Other immunosuppressants

7698

58259

1.43

144.88

1.3

1.22

1.73

u/ml

5.06

2020

15831

Reimbursement for rheumatic diseases

7676

57797

1.43

144.49

1.3

1.22

1.67

u/ml

3.71

2081

15495

Condition for Implicit Sepsis (Organ dysfunction codes)

11315

63055

1.34

143.29

1.3

1.65

1.70

u/ml

0.16

2795

17169

Fenamates

2016

7637

2.04

143.24

1.3

1.2

1.15

1.94

u/ml

1.84

498

2023

Migraine with aura and triptan purchases

2790

17805

1.89

143.09

1.4

1.3

1.01

1.64

u/ml

3.24

773

5073

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

3941

24061

1.71

142.91

1.5

1.4

1.77

u/ml

0.00

922

6645

Subjective visual disturbances

3491

23161

1.71

142.18

1.4

1.3

1.62

1.75

u/ml

0.24

784

6251

Cirrhosis of liver, NAS

770

3135

3.35

141.70

1.4

1.2

2.32

1.48

u/ml

0.71

154

823

Diabetic maculopathy

1752

9305

2.22

139.80

1.8

1.3

1.84

1.60

u/ml

0.37

595

2630

Soft tissue disorders related to use, overuse and pressure

3292

21463

1.70

139.24

1.3

1.2

1.38

1.83

u/ml

2.06

876

5761

Other arthritis (FG)

4102

28088

1.62

139.08

1.3

1.34

1.80

u/ml

1.88

1143

7591

Panic disorder

2540

15872

1.90

138.81

1.4

1.3

1.96

1.63

u/ml

0.43

611

4597

Oter anti-inflammatory and antirheumatic agents, non-steroids

2315

7312

1.90

138.59

1.3

1.2

1.06

2.15

u/ml

5.11

635

1916

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

4183

28744

1.62

138.58

1.4

1.3

1.24

1.69

u/ml

1.71

1053

8650

Asthma/COPD (KELA code 203)

13738

76426

1.30

137.29

1.3

1.53

1.76

u/ml

1.38

3785

20781

Injuries to the ankle and foot

10395

73145

1.35

136.98

1.4

1.3

1.86

1.69

u/ml

0.49

2606

20527

Urticaria

4546

32090

1.59

136.82

1.4

1.3

1.56

1.72

u/ml

0.38

1218

8829

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

8353

62783

1.40

136.36

1.3

1.54

1.60

u/ml

0.18

2134

17461

Nonorganic sleeping disorders

3110

20423

1.76

135.42

1.4

1.3

1.61

u/ml

0.00

764

5709

Intracranial trauma

8221

44091

1.40

135.16

1.3

1.82

1.86

u/ml

0.09

2200

12026

Allergic conjunctivitis

8707

66070

1.39

134.84

1.3

1.52

1.61

u/ml

0.30

2239

18325

Polycystic ovarian syndrome, consortium definition

11458

54306

1.35

134.47

1.3

1.31

1.55

u/ml

1.32

3127

14954

Disturbance of activity and attention

2341

14378

1.99

133.10

1.5

1.4

1.85

1.83

u/ml

0.02

528

3921

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

7717

52559

1.40

133.09

1.3

1.67

1.71

u/ml

0.12

1878

13889

Paracetamol or NSAID medication

2642

7992

1.83

132.93

1.3

1.4

1.81

2.43

u/ml

1.05

682

1950

Presence of other functional implants

6582

33726

1.44

132.30

1.4

1.2

1.54

1.76

u/ml

0.71

1978

8499

Postmenopausal osteoporosis with pathological fracture

914

4171

2.93

131.88

1.4

1.3

1.27

1.45

u/ml

0.23

263

994

Migraine without aura and triptan purchases

2867

18761

1.81

131.21

1.4

1.3

1.25

1.65

u/ml

1.40

842

5360

Non-invasive ventilation

2985

17165

1.71

129.66

1.3

1.2

3.90

1.82

u/ml

2.48

283

4907

External causes of morbidity and mortality

10162

39875

1.35

129.30

1.3

1.74

1.61

u/ml

0.40

2641

11720

Polyarthrosis

2416

13841

1.83

128.00

1.3

1.2

1.13

2.00

u/ml

5.79

705

3559

Sicca syndrome [Sjögren]

1306

6934

2.41

127.16

1.4

1.3

2.32

1.69

u/ml

0.73

370

1850

Thyroiditis, ILD-related definition

1829

10758

2.08

126.77

1.5

1.3

1.41

1.63

u/ml

0.41

497

2979

Papulosquamous disorders

4910

35360

1.52

126.44

1.3

1.75

1.65

u/ml

0.20

1333

9519

Benign neoplasm: Sigmoid colon

2159

13065

1.89

126.11

1.3

1.2

1.54

1.92

u/ml

0.71

518

3377

Cardiovascular diseases (excluding rheumatic etc)

10439

47659

1.34

126.09

1.3

1.61

1.75

u/ml

0.48

3016

13389

Any operation in hilmo

733

1375

3.13

125.93

1.3

1.1

1.38

1.89

u/ml

0.55

199

427

Obesity due to excess calories

6650

50402

1.43

125.65

1.3

1.54

1.63

u/ml

0.26

1855

14077

Benign neoplasm: Ascending colon

1627

9133

2.10

125.54

1.3

1.2

1.53

1.82

u/ml

0.43

365

2334

Postmenopausal atrophic vaginitis

3396

12384

1.69

125.03

1.3

1.2

1.37

1.78

u/ml

1.02

948

3245

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

7733

58831

1.39

124.95

1.3

1.60

1.65

u/ml

0.13

1816

16089

Hypertension

10613

47550

1.33

123.81

1.3

1.66

1.75

u/ml

0.27

3061

13360

Persistent mood disorders

2655

17059

1.77

123.46

1.4

1.3

1.15

1.64

u/ml

2.12

628

4775

Dermatophytosis

7970

61776

1.38

123.29

1.3

1.51

1.69

u/ml

0.75

2136

16944

Bipolar affective disorders

2841

18620

1.75

123.12

1.4

1.3

1.67

1.59

u/ml

0.11

719

5511

Other heart diseases, wide

13170

65729

1.29

122.83

1.3

1.60

1.72

u/ml

0.50

3591

18218

Hypertensive diseases

10613

47614

1.33

122.62

1.3

1.66

1.75

u/ml

0.27

3063

13378

Propionic acid derivatives

3946

13381

1.60

122.27

1.3

1.45

2.33

u/ml

3.06

1020

3343

Dipeptidyl peptidase 4 (DPP-4) inhibitors

5974

35408

1.44

121.89

1.3

1.2

1.59

1.79

u/ml

0.51

1485

9085

Hyperkinetic disorders

2423

15307

1.90

121.77

1.5

1.4

1.99

1.83

u/ml

0.16

549

4130

Chronic pancreatitis

1438

7836

2.15

120.56

1.4

1.2

1.82

2.17

u/ml

0.35

355

2063

Other extrapyramidal and movement disorders in other diseases

2903

19124

1.71

120.02

1.3

1.51

1.72

u/ml

0.33

736

5093

Diabetic retinopathy

4054

17625

1.60

119.75

1.6

1.3

1.89

1.57

u/ml

0.80

1150

4806

Exposure to other specified factors

10528

77787

1.32

119.40

1.3

1.73

u/ml

0.00

2579

21555

Disorders of lens

7594

36240

1.39

118.92

1.3

1.2

2.12

1.74

u/ml

1.14

1992

9722

Viral Sepsis

2476

15728

1.77

118.54

1.4

1.3

1.97

1.91

u/ml

0.06

609

4011

Injuries to the abdomen, lower back, lumbar spine and pelvis

4966

35753

1.49

118.54

1.3

1.77

1.69

u/ml

0.15

1261

9520

Covid-19 confirmed case

4504

32314

1.52

118.03

1.3

1.40

1.70

u/ml

1.10

1264

8586

Implicit viral Sepsis

2468

15690

1.77

117.73

1.4

1.3

1.97

1.90

u/ml

0.07

606

3996

Disorders of tooth development and eruption

2398

12192

1.80

117.57

1.3

1.21

1.81

u/ml

2.52

627

3549

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

7161

55065

1.39

117.13

1.3

1.64

u/ml

0.01

1679

14989

Injuries to the thorax

5222

38291

1.46

116.91

1.3

1.88

1.77

u/ml

0.20

1319

10233

Deforming dorsopathies

3666

25428

1.59

116.46

1.3

1.40

1.92

u/ml

1.71

1012

6697

Other disorders of glucose regulation and pancreatic internal secretion

1221

6462

2.33

116.41

1.7

1.3

2.00

1.73

u/ml

0.23

345

1648

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

4550

32979

1.52

115.39

1.4

1.3

1.63

1.74

u/ml

0.29

1178

8905

Paralytic ileus and intestinal obstruction

2633

16914

1.70

114.90

1.3

1.2

1.79

1.95

u/ml

0.22

693

4474

Other diseases of the digestive system

3386

23027

1.60

114.62

1.3

1.2

1.73

1.26

u/ml

1.27

825

5730

Benign neoplasm of other and ill-defined parts of digestive system

2179

13622

1.83

113.84

1.3

1.2

1.44

1.78

u/ml

0.58

608

3558

Other cataract

4822

26335

1.49

113.71

1.3

1.2

2.15

1.76

u/ml

0.82

1296

6814

Allergic rhinitis

4915

35886

1.50

113.49

1.4

1.3

1.50

1.76

u/ml

0.81

1350

9937

Allergic asthma (mode), excluding more controls

3675

25135

1.59

113.17

1.4

1.3

1.54

1.84

u/ml

0.71

1008

7212

Abnormal serum enzyme levels

2921

18814

1.65

113.03

1.3

1.2

1.72

1.91

u/ml

0.34

733

4795

Eating disorder

1811

11201

2.08

111.23

1.6

1.4

1.01

1.55

u/ml

2.67

471

3088

Hyperlipidaemia, other/unspecified

4032

26181

1.53

111.15

1.3

1.2

1.29

1.81

u/ml

2.98

1128

6737

Allergic asthma (mode)

3675

25241

1.58

110.78

1.4

1.3

1.54

1.85

u/ml

0.75

1008

7235

Eating disorders

2007

12658

1.96

110.74

1.6

1.4

1.06

1.52

u/ml

2.16

539

3489

Anti-inflammatory and antirheumatic products, non-steroids

3880

13387

1.56

110.22

1.3

1.65

2.33

u/ml

1.76

984

3344

Extrapyramidal and movement disorders

4283

30767

1.51

110.21

1.3

1.67

u/ml

0.01

1085

8023

Phobic anxiety disorders

2258

14491

1.83

109.80

1.4

1.3

1.45

1.74

u/ml

0.52

542

4181

Undetermined asthma, excluding more controls

1781

10649

1.93

109.77

1.4

1.3

1.42

1.90

u/ml

0.76

449

2895

Crohn disease

1887

11555

1.92

109.74

1.4

1.3

1.00

1.80

u/ml

5.21

489

3195

Endometriosis of pelvic peritoneum

2442

15135

1.77

109.68

1.3

1.27

1.70

u/ml

1.24

692

4240

Special screening examination for other diseases and disorders

1493

8474

2.03

109.16

1.4

1.2

1.94

1.70

u/ml

0.29

604

2325

Thyrotoxicosis, other and/or unspecified

2726

18177

1.70

108.08

1.4

1.3

1.89

1.70

u/ml

0.33

717

4870

Adhesive capsulitis of shoulder

1976

12150

1.84

107.76

1.4

1.2

1.58

2.01

u/ml

0.88

609

3262

Arthrosis

8766

37822

1.34

107.72

1.3

1.2

1.62

1.79

u/ml

0.55

2532

10494

Obesity, other/unspecified

4822

35685

1.48

107.56

1.3

1.60

1.64

u/ml

0.08

1248

10275

Emotionally unstable personality disorder

2129

13647

1.87

107.25

1.4

1.3

1.63

1.57

u/ml

0.06

471

3990

Undetermined asthma

1781

10729

1.91

106.82

1.4

1.3

1.42

1.93

u/ml

0.82

449

2927

Atopic dermatitis, strict definition

4821

35162

1.49

106.62

1.4

1.3

1.99

1.67

u/ml

0.77

1268

9796

Other and unspecified disorders of vitreous body

4720

34236

1.47

106.18

1.3

1.2

1.70

1.71

u/ml

0.02

1240

8753

Implicit bacterial Sepsis

4744

29933

1.46

105.40

1.3

1.2

1.80

1.81

u/ml

0.02

1068

7662

Hernia

12156

67080

1.27

104.09

1.3

1.73

1.71

u/ml

0.04

3125

18526

Infections of the skin and subcutaneous tissue

7744

60608

1.35

103.66

1.4

1.3

1.79

1.75

u/ml

0.09

1974

16708

Fracture of lumbar spine and pelvis

2454

15977

1.70

103.58

1.3

1.2

1.55

1.78

u/ml

0.38

585

4039

Impingement syndrome of shoulder

2688

17927

1.65

101.93

1.3

1.2

1.56

1.90

u/ml

0.79

670

4795

1979

12482

1.84

101.78

1.4

1.3

1.11

1.70

u/ml

2.42

465

3475

Diseases of tongue

831

3991

2.58

101.77

1.4

1.2

1.26

1.82

u/ml

0.79

221

1081

GI-bleeding

3306

22892

1.56

101.61

1.3

1.2

1.60

1.26

u/ml

0.90

817

5689

Injury, poisoning and certain other consequences of external causes

8253

32527

1.34

101.59

1.3

1.76

1.62

u/ml

0.36

2232

9263

Glucagon-like peptide-1 (GLP-1) analogues

3437

24174

1.56

101.37

1.3

1.20

1.81

u/ml

3.18

1017

6732

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

3437

24174

1.56

101.37

1.3

1.20

1.81

u/ml

3.18

1017

6732

Other eating disorders

1086

5993

2.51

101.23

1.6

1.4

1.10

1.74

u/ml

1.86

286

1598

Substance abuse, excluding more controls

6781

44803

1.36

101.00

1.3

1.66

1.81

u/ml

0.36

1649

12924

Asthma and allergy

2218

14214

1.78

100.99

1.4

1.3

1.35

1.78

u/ml

1.08

572

3997

Iron deficiency

611

2754

3.66

100.79

1.6

1.3

0.99

1.63

u/ml

1.28

211

742

Trochanteric bursitis

1802

11072

1.87

100.64

1.3

1.2

1.39

1.74

u/ml

0.84

505

2923

Asthma and allergy, excluding more controls

2219

14261

1.77

99.82

1.4

1.3

1.35

1.80

u/ml

1.13

572

4000

Senile cataract

6594

31035

1.37

98.90

1.3

1.2

2.14

1.74

u/ml

1.03

1652

8160

Implicit bacterial Sepsis

4249

27327

1.47

98.58

1.3

1.2

1.74

1.83

u/ml

0.13

948

6960

Benign neoplasm: Rectum

1962

12345

1.79

97.99

1.3

1.2

1.75

1.88

u/ml

0.16

435

3177

Other (not insulin) diabetes medications

12329

60547

1.26

97.49

1.3

1.2

1.54

1.69

u/ml

0.66

3391

16574

Percutaneous Coronary Intervention

9204

45332

1.31

97.41

1.3

1.52

1.84

u/ml

1.74

2695

11726

Other bacterial intestinal infections

2120

13600

1.74

96.91

1.4

1.3

1.69

1.82

u/ml

0.15

492

3582

Mycoses

3281

23103

1.57

96.87

1.3

2.15

1.73

u/ml

0.68

831

6238

Emergency coronary revascularization (for ACS)

9781

48080

1.29

96.87

1.3

1.52

1.81

u/ml

1.57

2849

12391

Fracture of rib(s), sternum and thoracic spine

3210

22403

1.55

96.03

1.3

1.2

1.84

1.75

u/ml

0.12

789

5883

Female infertility

4575

20545

1.49

96.01

1.3

1.43

1.63

u/ml

0.56

1457

5692

Unspecified/other endometriosis

1535

9283

2.00

95.97

1.4

1.3

1.37

1.73

u/ml

0.57

409

2684

Injuries to the knee and lower leg

16730

79147

1.22

95.65

1.3

1.81

1.67

u/ml

0.56

4346

21689

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

13339

72784

1.25

95.24

1.3

1.58

1.71

u/ml

0.55

3673

19809

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

2456

16467

1.69

95.20

1.3

1.49

1.79

u/ml

0.55

624

4629

Post-traumatic stress disorder

1522

9277

2.02

94.76

1.4

1.3

1.29

1.51

u/ml

0.37

377

2731

Infections with a predominantly sexual mode of transmission

6229

45379

1.39

94.72

1.4

1.3

1.86

1.56

u/ml

0.75

1560

13177

Trigger finger

1793

11149

1.83

94.71

1.4

1.2

1.58

1.88

u/ml

0.43

496

3022

Gonarthrosis

7391

32941

1.34

94.66

1.3

1.2

1.58

1.84

u/ml

0.91

2078

9013

Chronic laryngitis and laryngotracheitis

1714

10553

1.86

94.50

1.3

1.2

0.99

1.80

u/ml

4.91

296

2924

Other menopausal disorders

3605

14391

1.55

94.45

1.3

1.00

1.73

u/ml

4.66

1027

3899

Hypo-osmolality and hyponatraemia

1905

11893

1.77

94.36

1.4

1.2

1.76

1.92

u/ml

0.18

514

3025

Ulcerative colitis (strict definition, require KELA)

2303

15283

1.71

94.01

1.3

1.54

1.76

u/ml

0.34

581

4304

Cervicocranial syndrome

1412

8294

1.99

93.78

1.3

1.2

1.16

1.80

u/ml

1.53

450

2217

Gastroduodenal ulcer

2438

16060

1.63

93.18

1.3

1.2

1.85

u/ml

0.00

620

4211

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

2237

14788

1.72

93.12

1.3

1.57

1.77

u/ml

0.29

566

4156

Benign neoplasm: Rectum, anus and anal canal

2157

14022

1.71

93.01

1.3

1.2

1.69

1.82

u/ml

0.18

475

3626

Continuous positive airway pressure

2021

10763

1.73

92.67

1.3

1.2

2.25

2.22

u/ml

0.03

329

2915

Internal derangement of knee

4577

33981

1.43

92.18

1.3

1.56

1.82

u/ml

0.59

1233

9422

Benign neoplasm: Caecum

1213

6858

2.08

91.82

1.3

1.2

1.36

1.85

u/ml

0.86

291

1730

Coronary revascularization (ANGIO or CABG)

9164

45363

1.30

91.65

1.3

1.52

1.84

u/ml

1.73

2689

11736

Bleeding

9782

56786

1.28

91.50

1.3

1.80

1.73

u/ml

0.17

2525

15010

Enthesopathies of lower limb, excluding foot

2745

18863

1.60

91.17

1.3

1.19

1.97

u/ml

4.40

715

5165

Ischemic heart diseases

9785

47876

1.29

90.99

1.3

1.51

1.82

u/ml

1.79

2873

12453

Ulcerative colitis (strict definition, all Crohn cases excluded)

1978

12795

1.77

90.86

1.3

1.67

1.76

u/ml

0.11

506

3560

Artrosis, including avohilmo

10499

47054

1.27

90.66

1.3

1.53

1.74

u/ml

1.02

3055

13053

Pollen allergy

3123

22032

1.59

90.65

1.4

1.55

1.83

u/ml

0.59

764

6029

Thyrotoxicosis

3325

23824

1.55

90.56

1.4

1.3

1.80

1.62

u/ml

0.36

878

6490

Other and unspecified effects of external causes

3933

29007

1.49

90.49

1.4

1.3

1.65

1.69

u/ml

0.06

1053

8066

Diseases of male genital organs

5165

19408

1.41

90.43

1.3

2.19

2.17

u/ml

0.03

1382

5296

Female infertility, cervical, vaginal, other or unspecified origin

4138

19819

1.49

90.23

1.3

1.43

1.62

u/ml

0.49

1292

5523

Tonsillectomy and adenotomy

8909

50505

1.31

90.20

1.3

1.55

1.70

u/ml

0.44

2350

14648

Disorders of vestibular function (Vertigo)

5428

41042

1.39

89.73

1.3

1.73

1.63

u/ml

0.20

1342

10819

Deviated nasal septum

3591

25844

1.49

89.63

1.3

1.91

1.82

u/ml

0.11

943

7243

Neoplasms

11695

51469

1.26

89.37

1.3

1.48

1.81

u/ml

2.26

3180

14794

Benign neoplasm: Stomach

1189

6763

2.09

89.26

1.3

1.2

1.70

1.59

u/ml

0.11

318

1752

Mouth breathing

4679

35264

1.43

88.93

1.3

1.62

1.87

u/ml

0.68

1257

9408

Transport accidents

6364

42916

1.35

88.50

1.3

2.06

1.59

u/ml

1.25

1652

12673

Hypoglycaemia, other or unspecified

962

5159

2.29

88.41

1.7

1.3

1.67

1.62

u/ml

0.04

275

1322

Chronic kidney disease

2887

19626

1.55

87.50

1.3

2.27

1.92

u/ml

0.43

688

4853

Restless leg syndrome

1720

10877

1.83

87.46

1.4

1.3

1.59

1.67

u/ml

0.07

467

2911

All kidney diseases

13397

77405

1.23

87.33

1.3

1.70

1.69

u/ml

0.05

3466

21267

Monoamine oxidase A inhibitors

1421

8502

1.92

87.04

1.3

1.2

1.31

1.73

u/ml

0.82

365

2315

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

2667

18685

1.64

86.97

1.4

1.3

1.32

1.52

u/ml

0.39

693

5370

Exclusions for E4_PCOS_BROAD

2355

15980

1.67

86.79

1.4

1.31

1.93

u/ml

2.46

690

4215

Asthma-related pneumonia or sepsis

4141

30650

1.44

86.76

1.3

1.74

1.87

u/ml

0.21

1074

7939

Asthma, hospital admissions 3, pneumonia

4141

30650

1.44

86.76

1.3

1.74

1.87

u/ml

0.21

1074

7939

Asthma-related pneumonia

4130

30564

1.45

86.63

1.3

1.73

1.86

u/ml

0.20

1072

7912

Gonarthrosis [arthrosis of knee](FG)

8690

40758

1.29

86.57

1.3

1.2

1.74

1.79

u/ml

0.11

2411

11100

Other heart diseases

6717

34574

1.35

86.54

1.3

1.62

1.82

u/ml

0.66

1862

9666

All chronic kidney diseases

6148

39240

1.35

86.43

1.4

1.3

1.81

1.78

u/ml

0.05

1601

10198

Stomatitis and related lesions

2626

18219

1.62

86.26

1.4

1.3

1.49

1.77

u/ml

0.64

664

4916

Heart failure, not strict

8279

45348

1.30

85.91

1.3

1.85

1.74

u/ml

0.26

2063

11879

Recurrent aphthous stomatitis , including avohilmo

1949

12767

1.76

85.80

1.4

1.3

1.47

1.79

u/ml

0.64

501

3322

Other and unspecified urticaria

2798

19701

1.60

85.79

1.4

1.3

1.50

1.69

u/ml

0.32

717

5402

Other disorders of eyelid

4758

34305

1.41

85.70

1.3

1.2

1.49

1.70

u/ml

0.60

1170

8797

Female genital prolapse

3708

15147

1.50

85.51

1.3

1.25

1.77

u/ml

2.30

1013

4072

Renal failure

4466

29516

1.42

85.44

1.3

1.2

1.92

1.86

u/ml

0.08

1034

7432

Lichen simplex chronicus and prurigo

835

4313

2.39

85.23

1.4

1.2

2.06

1.50

u/ml

0.59

205

1140

Other sleep disorders

1409

8497

1.91

84.31

1.4

1.3

1.46

2.27

u/ml

1.59

470

2288

Obsessive-compulsive disorder

1189

6997

2.12

84.05

1.5

1.3

1.66

1.46

u/ml

0.19

293

1959

Adenomyosis (Endometriosis of uterus)

1737

11115

1.79

83.00

1.3

1.20

1.83

u/ml

2.28

426

2988

Ulcer of lower limb, not elsewhere classified

1465

8898

1.85

82.91

1.4

1.2

1.71

1.87

u/ml

0.20

342

2265

Injuries to the head

15379

81059

1.21

82.91

1.3

1.68

1.71

u/ml

0.10

3962

22238

Tinnitus

2767

19427

1.57

82.79

1.3

1.2

1.50

1.79

u/ml

0.57

642

5209

Intracranial injury

7430

56633

1.31

82.43

1.3

1.68

1.78

u/ml

0.24

1926

15174

Mucosal proctocolitis

1731

11104

1.79

82.33

1.3

1.15

1.76

u/ml

1.63

415

3117

Inflammatory diseases of prostate (prostatitis)

1140

6439

1.97

81.62

1.3

1.2

2.78

1.97

u/ml

0.65

259

1741

Fibroblastic disorders

2357

15957

1.60

81.45

1.3

1.2

2.07

1.95

u/ml

0.13

552

4208

Vascular disorders of the intestines

673

3193

2.44

80.97

1.3

1.2

2.02

1.90

u/ml

0.07

159

829

Bacterial intestinal infections, IBD co-morbidities

2101

14013

1.66

80.78

1.4

1.3

1.59

1.79

u/ml

0.24

481

3673

Bacterial Sepsis

4885

31878

1.38

80.74

1.3

1.95

1.80

u/ml

0.26

1110

8188

STROKE

6365

34112

1.34

80.45

1.3

1.2

1.29

1.78

u/ml

3.40

1681

8930

Diseases of inner ear

6204

47534

1.34

80.22

1.3

1.71

1.63

u/ml

0.17

1524

12644

Non-allergic asthma (mode), excluding more controls

2406

16363

1.60

79.63

1.3

1.22

2.00

u/ml

3.90

681

4367

Crohn's disease of small intestine

1022

5804

2.16

79.60

1.4

1.3

0.88

1.65

u/ml

3.07

282

1599

Benign neoplasm: Transverse colon

1165

6774

1.99

79.57

1.3

1.2

1.19

1.86

u/ml

1.65

286

1727

Other general symptoms and signs

843

4484

2.36

79.18

1.5

1.4

2.26

1.91

u/ml

0.23

244

1153

L04AA Selective immunosuppressants

2862

20459

1.55

79.01

1.3

1.33

1.69

u/ml

0.90

752

5573

Hard cardiovascular diseases

9960

49182

1.26

78.89

1.3

1.52

1.80

u/ml

1.55

2843

12972

Rheumatoid arthritis

3687

24395

1.45

78.74

1.3

1.2

1.10

1.80

u/ml

5.12

964

6517

Other neurological diseases

8197

52540

1.28

78.34

1.3

1.51

1.70

u/ml

0.72

2181

13730

Radiculopathy

1735

11127

1.72

78.23

1.3

1.2

1.80

1.99

u/ml

0.18

490

2861

Other disorders of ear

11470

63152

1.24

78.14

1.3

1.53

1.75

u/ml

1.25

2985

17039

Abnormal results of function studies

1175

6944

2.01

78.11

1.4

1.3

1.29

1.82

u/ml

1.15

308

1820

Thyrotoxicosis with diffuse goitre

1921

12777

1.71

78.08

1.4

1.3

1.83

1.51

u/ml

0.49

525

3485

Vitreous haemorrhage

1165

6827

1.97

77.49

1.6

1.2

1.90

1.73

u/ml

0.16

340

1781

3889

26547

1.43

77.45

1.3

1.2

1.92

1.77

u/ml

0.23

952

6432

Bullous disorders

732

3731

2.41

77.30

1.6

1.2

4.67

1.63

u/ml

3.23

229

950

Atrial fibrillation and flutter with reimbursement

2775

12301

1.54

77.26

1.3

1.2

1.92

1.88

u/ml

0.04

728

3264

Viral and other specified intestinal infections

3295

23646

1.50

77.19

1.5

1.3

1.82

1.83

u/ml

0.01

933

6267

Ulcerative colitis, NAS

1832

12072

1.72

76.92

1.3

1.33

1.83

u/ml

1.37

468

3331

Diseases of salivary glands

4039

30564

1.43

76.83

1.3

1.50

1.71

u/ml

0.46

1059

8325

Non-allergic asthma (mode)

2407

16491

1.58

76.74

1.3

1.22

1.98

u/ml

3.81

681

4417

Psoriasis

3348

24587

1.48

76.61

1.3

1.81

1.68

u/ml

0.20

892

6710

Herpesviral [herpes simplex] infections

3453

25635

1.48

76.58

1.3

1.29

1.63

u/ml

1.19

947

7164

Other disorders of bladder

1235

7330

1.90

76.43

1.3

1.2

2.31

1.72

u/ml

0.57

295

1918

Adverse effects, not elsewhere classified

2786

20017

1.56

76.28

1.4

1.3

1.60

1.63

u/ml

0.04

728

5506

Disorders of sclera, cornea, iris and ciliary body

6823

55075

1.31

76.06

1.3

1.75

1.67

u/ml

0.17

1985

15009

Postmenopausal bleeding

3103

11804

1.52

76.01

1.3

1.2

1.67

1.79

u/ml

0.16

748

3054

Skin changes due to chronic exposure to nonionizing radiation

3606

24553

1.44

75.84

1.3

1.2

1.94

1.79

u/ml

0.20

886

5904

Diseases of arteries, arterioles and capillaries (FINNGEN)

2645

12734

1.55

75.70

1.3

1.2

1.47

1.92

u/ml

0.97

651

3357

Biological medication for rheuma

2405

16865

1.61

75.48

1.3

1.34

1.70

u/ml

0.82

704

4769

Chronic hepatitis, not elsewhere classified

534

2479

2.93

75.43

1.5

1.2

1.37

1.67

u/ml

0.38

124

656

Other noninflammatory disorders of vulva and perineum

1354

8400

1.89

75.19

1.3

1.57

1.78

u/ml

0.18

341

2310

Other CVD (FINNGEN)

1269

5837

1.89

75.13

1.3

1.2

1.61

1.88

u/ml

0.21

307

1427

Use of pramipexole

2446

17091

1.57

74.81

1.3

1.2

1.62

1.77

u/ml

0.26

677

4451

Coxarthrosis

5208

26584

1.36

74.80

1.3

1.2

1.65

1.84

u/ml

0.45

1341

7057

Lichen ruber planus, wide definition including periferal and oral lichen planus

2566

18146

1.56

74.51

1.3

1.73

1.72

u/ml

0.01

713

4782

Fall on same level involving ice and snow

7160

58238

1.30

74.50

1.3

1.91

1.63

u/ml

0.81

1821

15623

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

4304

32809

1.42

74.22

1.5

1.3

1.72

1.66

u/ml

0.11

1078

9271

Injuries to the wrist and hand

13699

81505

1.21

74.19

1.3

1.56

1.72

u/ml

0.75

3560

22344

Allergic contact dermatitis

1877

12567

1.70

74.19

1.4

1.3

1.99

1.51

u/ml

0.79

456

3525

Other enthesopathy of foot (+metatarsalgia)

1343

8301

1.87

74.18

1.3

1.2

1.45

1.69

u/ml

0.30

323

2222

Gastric ulcer

1670

10700

1.70

74.02

1.3

1.2

1.29

1.97

u/ml

1.73

418

2812

Viral hepatitis, IBD co-morbidity

664

3265

2.36

73.44

1.3

1.2

1.69

2.43

u/ml

0.64

125

955

Amenorrhoea

1186

7230

2.00

73.23

1.5

1.3

2.06

1.84

u/ml

0.17

346

2017

Actinic keratosis

3464

23687

1.44

72.65

1.3

1.2

1.88

1.81

u/ml

0.09

857

5684

Major coronary heart disease event

9558

47941

1.25

72.61

1.3

1.49

1.83

u/ml

2.06

2778

12403

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

5494

27739

1.38

72.47

1.3

1.16

1.49

u/ml

2.09

1628

8226

Other obstetric conditions, not elsewhere classified

5587

28320

1.37

72.18

1.3

1.15

1.53

u/ml

2.65

1658

8406

Spondylolisthesis/Spondylolysis

2067

14057

1.62

72.15

1.3

1.2

1.04

1.97

u/ml

4.15

580

3687

Other or unspecified ileus, impaction or obstruction

1727

11209

1.67

71.98

1.3

1.2

1.45

2.07

u/ml

1.37

457

2934

Abnormal involuntary movements

1637

10681

1.74

71.58

1.4

1.3

1.56

1.86

u/ml

0.31

414

2774

Diseases of middle ear and mastoid

8186

55403

1.28

71.26

1.4

1.3

2.05

1.61

u/ml

1.56

2108

15535

Zoster [herpes zoster]

5652

44252

1.33

71.10

1.3

1.69

1.66

u/ml

0.06

1494

11557

Injuries to the elbow and forearm

9481

69924

1.25

70.79

1.3

2.08

1.66

u/ml

1.65

2362

18877

Other shoulder lesions

1223

7465

1.89

70.53

1.3

1.2

1.34

1.86

u/ml

0.66

299

2027

Abnormalities of gait and mobility

1318

8176

1.83

70.36

1.3

1.50

1.92

u/ml

0.72

254

1991

Unspecified fall

6125

48526

1.31

70.17

1.4

1.3

2.02

1.75

u/ml

0.64

1308

12847

Poisoning by drugs, medicaments and biological substances

3326

24863

1.47

70.11

1.4

1.3

1.20

1.65

u/ml

1.74

792

7058

Persons encountering health services for specific procedures, not carried out

1190

7273

1.93

70.09

1.4

1.3

1.34

1.71

u/ml

0.34

207

1976

Metatarsalgia

1239

7621

1.88

69.86

1.3

1.2

1.56

1.66

u/ml

0.09

288

2031

Congenital malformations, deformations and chromosomal abnormalities

9085

70153

1.25

69.83

1.3

1.64

1.69

u/ml

0.13

2416

19547

Disorders of parathyroid gland

2279

15726

1.57

69.22

1.3

1.2

1.36

1.69

u/ml

0.69

572

3967

Other acute lower respiratory infections

6571

50755

1.30

69.21

1.4

1.3

1.51

1.79

u/ml

1.09

1671

13525

Other maternal disorders predominantly related to pregnancy

8597

44938

1.28

69.21

1.3

1.48

1.52

u/ml

0.10

2634

12385

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

6000

30227

1.32

69.09

1.3

1.57

1.71

u/ml

0.35

1778

8688

Oesophageal varices

518

2422

2.70

68.71

1.4

1.3

3.01

1.68

u/ml

0.66

621

Brachial plexus disorders

1320

8329

1.85

68.67

1.4

1.3

1.10

1.68

u/ml

2.12

501

2411

Renal tubulo-interstitial diseases

11156

70657

1.22

68.53

1.3

1.62

1.69

u/ml

0.20

2836

19112

Hyperplasia of prostate

2814

11276

1.49

68.48

1.2

2.17

2.19

u/ml

0.02

699

3035

Abrasion of teeth

4197

32457

1.39

68.47

1.3

1.60

1.67

u/ml

0.13

1104

9001

Exclusions for E4_PCOS_CONSORTIUM

10725

57039

1.24

68.25

1.3

1.37

1.64

u/ml

1.53

2874

15806

Necrosis of pulp, including avohilmo

7547

62171

1.28

67.94

1.3

1.60

1.68

u/ml

0.21

2146

17466

Convulsions, not elsewhere classified

2957

21393

1.47

67.67

1.4

1.3

1.95

1.97

u/ml

0.03

704

5704

Prurigo nodularis

369

1520

3.38

67.56

1.4

1.2

2.36

1.55

u/ml

0.48

405

Alcoholic liver disease

1000

5795

1.95

67.50

1.3

1.2

3.02

2.10

u/ml

0.67

185

1586

Persons with potential health hazards related to communicable diseases

5672

45314

1.33

67.15

1.4

1.3

1.20

1.74

u/ml

4.02

2200

12319

Inflammatory disease of uterus

2132

15023

1.62

67.12

1.3

1.26

1.52

u/ml

0.54

572

4369

Mixed and other personality disorders

1155

7120

1.93

66.64

1.4

1.3

1.59

1.63

u/ml

0.04

260

2076

Poisoning by medicine

3020

22443

1.48

66.42

1.4

1.3

1.25

1.67

u/ml

1.39

727

6383

Candidiasis

1752

11829

1.68

66.32

1.4

1.3

2.23

1.58

u/ml

0.72

396

3162

Gout

2331

14306

1.52

66.28

1.2

2.07

2.11

u/ml

0.04

538

3562

Elevated blood glucose level

1035

6160

1.96

66.27

1.6

1.3

2.71

1.83

u/ml

0.71

247

1599

Meniscus derangement

6225

33702

1.30

66.13

1.3

1.2

1.52

1.81

u/ml

1.11

1656

9261

Lateral epicondylitis

1579

10363

1.70

66.00

1.3

1.2

1.78

1.97

u/ml

0.19

487

2904

Disorders of mineral metabolism

1021

6050

1.96

65.94

1.4

1.3

1.14

1.80

u/ml

1.45

268

1582

Other protozoal intestinal diseases

393

1714

3.35

65.85

1.5

1.3

1.78

1.63

u/ml

0.06

446

Iron deficiency anaemia secondary to blood loss (chronic)

1727

11525

1.65

65.78

1.3

1.2

1.64

1.69

u/ml

0.05

425

2994

Childhood asthma (age<16), excluding more controls

2363

13269

1.57

65.68

1.4

1.3

1.90

1.89

u/ml

0.01

629

3743

Primary biliary cholangitis (PBC)

347

1413

3.50

65.68

1.5

1.2

0.71

1.14

u/ml

0.72

363

Viral infections characterized by skin and mucous membrane lesions

5163

41056

1.33

65.66

1.4

1.3

1.93

1.74

u/ml

0.42

1360

11088

Injuries to the shoulder and upper arm

10430

71356

1.22

65.61

1.3

1.92

1.70

u/ml

0.71

2729

19232

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

4183

32607

1.39

65.41

1.4

1.3

1.24

1.62

u/ml

1.34

1053

9394

Childhood asthma (age<16)

2364

13293

1.57

65.39

1.4

1.3

1.90

1.89

u/ml

0.01

629

3746

Coxarthrosis [arthrosis of hip](FG)

5649

31650

1.31

64.94

1.3

1.2

1.62

1.80

u/ml

0.47

1428

8309

Other inflammatory liver diseases

837

4735

2.11

64.57

1.4

1.3

1.22

1.56

u/ml

0.65

190

1274

Maternal care for other conditions predominantly related to pregnancy

3284

24463

1.46

64.51

1.3

1.31

1.46

u/ml

0.40

1012

7190

Acute bronchitis

4762

36795

1.34

64.11

1.4

1.3

1.45

1.78

u/ml

1.11

1209

9739

Abnormal findings on diagnostic imaging of lung

4768

35936

1.34

64.06

1.3

1.2

1.77

1.72

u/ml

0.10

1086

9272

Atrial fibrillation and flutter

3524

17129

1.42

64.00

1.3

1.2

1.67

1.85

u/ml

0.35

963

4739

ILD medications: azathioprine

1940

13421

1.61

63.94

1.4

1.3

1.22

1.80

u/ml

2.35

503

3658

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

11734

64355

1.21

63.81

1.3

1.48

1.72

u/ml

1.31

3202

17684

11917

61883

1.21

63.74

1.3

1.76

1.74

u/ml

0.05

3026

16981

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

11917

61883

1.21

63.74

1.3

1.76

1.74

u/ml

0.05

3026

16981

Hypokalaemia

1358

8680

1.75

63.72

1.4

1.2

1.22

1.88

u/ml

1.59

325

2259

Azathioprine

1940

13436

1.61

63.58

1.4

1.3

1.22

1.81

u/ml

2.45

503

3658

Colonic or urogenital fistula

3072

22926

1.45

63.31

1.3

1.20

1.71

u/ml

2.12

802

6297

Social phobias

1375

8975

1.79

62.97

1.4

1.3

1.46

1.62

u/ml

0.23

313

2554

Diseases of external ear

3943

30510

1.38

62.84

1.4

1.3

1.71

1.78

u/ml

0.11

893

8142

Alcohol use disorder, Swedish definition

6067

45074

1.29

62.78

1.3

1.83

1.84

u/ml

0.02

1509

12626

Erosion of teeth , including avohilmo

3387

25816

1.43

62.74

1.4

1.3

1.53

1.66

u/ml

0.25

837

7271

Pain associated with micturition

1452

9517

1.73

62.63

1.3

1.87

1.79

u/ml

0.07

337

2479

Psychotic depression

778

4310

2.11

62.53

1.4

1.3

0.82

1.62

u/ml

3.80

194

1218

Hallux valgus (acquired)

3939

21799

1.38

61.63

1.2

1.54

1.87

u/ml

0.79

964

5920

Other/unspecified synovitis and tenosynovitis

1372

8871

1.73

61.51

1.4

1.2

1.71

1.84

u/ml

0.13

374

2378

Other inflammation of eyelid

1648

11136

1.66

61.36

1.3

1.75

1.84

u/ml

0.09

374

2924

Tumor necrosis factor alpha inhibitors

2127

15155

1.57

61.17

1.3

1.41

1.73

u/ml

0.61

633

4294

Anorexia (incl.atypical)

1024

6314

1.99

61.16

1.6

1.3

1.06

1.74

u/ml

2.22

281

1703

Polyp of the female genital tract

3901

17206

1.40

61.10

1.3

1.33

1.70

u/ml

1.04

973

4685

Vitamin B12 deficiency anaemia

1054

6353

1.85

61.10

1.4

1.2

2.35

1.48

u/ml

0.75

231

1633

Other viral diseases

5336

42781

1.32

61.10

1.4

1.3

1.39

1.77

u/ml

1.53

1483

11881

Acute renal failure

2035

14180

1.55

61.03

1.3

1.2

1.92

1.95

u/ml

0.02

460

3603

Type 2 diabetes, definitions combined

11598

58403

1.21

60.93

1.3

1.2

1.52

1.70

u/ml

0.78

3204

15975

Type 2 diabetes, strict (exclude DM1)

11632

58592

1.21

60.93

1.3

1.2

1.52

1.70

u/ml

0.78

3213

16028

Other disorders of eye and adnexa

1861

12945

1.62

60.79

1.4

1.3

1.12

1.74

u/ml

2.43

419

3537

Crohn disease (strict definition, all UC cases excluded)

759

4296

2.19

60.61

1.4

1.3

0.82

1.74

u/ml

2.59

192

1169

Carbimazole or st.post thyroidectomy, condition for graves disease

2678

19815

1.49

60.52

1.3

1.89

1.52

u/ml

0.80

680

5472

Other disorders of veins

4745

37553

1.33

60.17

1.3

1.37

1.64

u/ml

0.88

1091

10139

Blepharochalasis

3048

22878

1.43

59.92

1.3

1.2

1.30

1.76

u/ml

1.95

764

5829

Periodontitis

11922

68791

1.20

59.92

1.3

1.64

1.69

u/ml

0.17

2988

19164

Paroxysmal tachycardia

2793

17255

1.46

59.90

1.3

1.44

1.72

u/ml

0.69

756

4596

Autoimmune hyperthyroidism

845

4906

2.05

59.88

1.4

1.2

1.85

1.13

u/ml

1.10

214

1304

Heart failure and antihypertensive medication

2474

11567

1.49

59.85

1.3

1.2

1.89

2.12

u/ml

0.26

622

3064

Emotional disorders starting during childhood or adolecense, excluding more controls

892

5239

2.11

59.83

1.7

1.5

1.72

2.09

u/ml

0.34

195

1359

Other diseases of stomach and duodenum

710

3867

2.14

59.80

1.4

1.2

1.35

1.61

u/ml

0.33

161

1006

Mental and behavioural disorders due to psychoactive substance use

7044

54030

1.26

59.77

1.3

1.64

1.80

u/ml

0.41

1727

15136

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

988

6030

1.96

59.75

1.4

1.3

0.88

1.57

u/ml

2.39

244

1647

Lichen planus, including avohilmo

2132

15191

1.54

59.40

1.3

1.2

1.69

1.75

u/ml

0.08

586

3978

Chronic periodontitis, including avohilmo

11875

68710

1.20

59.23

1.3

1.61

1.69

u/ml

0.26

2977

19125

6554

48688

1.27

59.13

1.3

1.78

1.80

u/ml

0.04

1621

13578

Other disorders of patella

2198

15750

1.53

59.04

1.3

1.51

1.94

u/ml

0.85

572

4486

Injuries to the hip and thigh

5115

37088

1.31

58.96

1.3

1.70

1.75

u/ml

0.12

1284

9612

Other metabolic disorders

1764

12207

1.62

58.91

1.3

1.54

1.50

u/ml

0.06

498

3393

Other and unspecified nerve root and plexus disorders, also in other diseases

2281

16431

1.51

58.85

1.3

1.2

1.75

1.78

u/ml

0.03

483

4561

Ascites

785

4426

2.03

58.68

1.3

1.2

3.76

1.96

u/ml

1.04

180

1186

Non-rheumatic valve diseases

4856

27787

1.32

58.65

1.3

2.08

1.81

u/ml

0.53

1275

7059

Hypotension

1553

10332

1.63

58.61

1.3

1.2

1.55

1.67

u/ml

0.10

369

2560

Other CVD

1832

12614

1.57

58.41

1.3

1.2

1.57

1.81

u/ml

0.26

427

3139

Type 2 diabetes, definitions combined, including avohilmo

11700

58674

1.20

58.33

1.3

1.2

1.56

1.69

u/ml

0.51

3242

16076

Crohn disease (strict definition, require KELA)

933

5653

1.99

58.19

1.4

1.3

0.89

1.56

u/ml

2.10

232

1544

Enlarged lymph nodes

1872

13033

1.57

58.10

1.3

1.48

1.96

u/ml

1.24

554

3498

Implicit fungal Sepsis

830

4826

2.03

58.08

1.4

1.2

1.74

1.56

u/ml

0.12

175

1259

Crohn disease (strict definition, require KELA, min 2 HDR)

924

5597

1.99

57.76

1.4

1.3

0.89

1.57

u/ml

2.13

232

1524

6-mercaptopurine

570

3010

2.47

57.65

1.4

1.3

1.06

1.82

u/ml

0.84

150

803

Substance abuse

6781

52750

1.26

57.60

1.3

1.66

1.81

u/ml

0.36

1649

14811

Ischaemic heart disease, wide definition

8184

42453

1.24

57.44

1.3

1.2

1.53

1.81

u/ml

1.12

2235

11115

All influenza

2924

21983

1.43

56.79

1.4

1.3

1.80

u/ml

0.01

769

5816

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2302

16832

1.52

56.78

1.4

1.3

1.20

1.74

u/ml

1.51

553

4796

Degeneration of macula and posterior pole

4412

27656

1.33

56.71

1.3

1.2

1.71

1.76

u/ml

0.08

1084

6728

Small fibre neuropathy

392

1788

2.89

56.70

1.5

1.2

0.99

1.55

u/ml

0.86

474

Barrett oesophagus

524

2624

2.38

56.64

1.3

1.2

2.06

1.79

u/ml

0.16

701

Lactose intolerance

497

2511

2.60

56.51

1.5

1.3

1.24

1.85

u/ml

0.77

109

652

Disorders of ocular muscles, binocular movement, accommodation and refraction

6330

51964

1.28

56.36

1.4

1.3

1.55

1.73

u/ml

0.51

1762

14098

Benign paroxysmal vertigo

3220

24618

1.40

56.29

1.3

1.74

1.68

u/ml

0.09

801

6468

Valvular heart disease excluding rheumatic fever

4881

28114

1.31

56.15

1.3

2.07

1.82

u/ml

0.50

1280

7123

Glomerular disorders in diseases classified elsewhere

1232

7933

1.74

56.04

1.5

1.2

2.42

1.89

u/ml

0.50

340

2068

Covid-19 suspected case

3010

22925

1.43

56.02

1.3

1.59

1.68

u/ml

0.14

847

6382

Postprocedural endocrine and metabolic disorders, not elsewhere classified

1634

11256

1.63

56.01

1.3

1.56

1.44

u/ml

0.19

467

3169

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

5360

43574

1.30

55.52

1.3

1.87

1.67

u/ml

0.37

1361

12373

Arthropathies in other diseases classified elsewhere

468

2289

2.54

55.45

1.6

1.2

1.60

1.87

u/ml

0.20

129

588

6914

50628

1.25

55.38

1.3

1.80

u/ml

0.01

1723

14142

Rosacea

1461

9871

1.68

55.38

1.4

1.3

1.48

1.58

u/ml

0.14

412

2738

Sensorineural hearing loss

8150

46515

1.23

55.31

1.3

1.68

1.75

u/ml

0.18

2142

12153

Congenital malformations, deformations and chromosomal abnormalities

8196

66208

1.23

55.24

1.3

1.65

1.69

u/ml

0.09

2210

18487

Ganglion

2607

19387

1.45

55.23

1.3

1.2

1.98

1.82

u/ml

0.21

741

5437

Infections with a predominantly sexual mode of transmission

4423

35422

1.34

55.15

1.4

1.3

2.18

1.50

u/ml

1.53

1026

10338

Dermatographic urticaria

979

6101

1.92

55.12

1.4

1.3

1.22

1.51

u/ml

0.49

309

1693

Biguanides

11737

61945

1.19

55.04

1.3

1.61

1.72

u/ml

0.37

3175

17056

Other and unspecified mood [affective] disorders

1110

7111

1.83

55.03

1.4

1.3

0.92

1.54

u/ml

2.35

241

2037

Endometriosis of ovary

2183

15447

1.51

55.03

1.3

1.15

1.73

u/ml

2.10

570

4258

Other diseases of oesophagus

960

5811

1.84

55.02

1.3

1.2

1.62

1.89

u/ml

0.23

242

1515

Conductive and sensorineural hearing loss

8789

50224

1.22

54.93

1.3

1.64

1.75

u/ml

0.34

2328

13238

Psoriasis vulgaris

2091

15029

1.52

54.82

1.3

2.08

1.81

u/ml

0.33

576

4110

Injuries to the neck

2886

21877

1.43

54.65

1.4

1.3

1.40

1.70

u/ml

0.71

768

6138

Other abnormal uterine and vaginal bleeding

2818

15119

1.44

54.51

1.3

1.49

1.71

u/ml

0.38

668

4058

Diabetes mellitus in pregnancy

5260

27457

1.32

54.46

1.4

1.3

1.62

1.52

u/ml

0.24

1687

8048

Cellulitis

2531

18784

1.46

54.28

1.4

1.3

2.14

1.90

u/ml

0.30

621

5064

Cerebrovascular diseases (FINNGEN)

3597

19647

1.37

54.22

1.3

1.2

1.29

1.71

u/ml

1.72

957

5454

Cutaneous abscess, furuncle and carbuncle

3131

23997

1.40

54.05

1.4

1.3

1.86

1.81

u/ml

0.06

794

6707

Conjunctivitis (acute, non atopic)

3610

28161

1.37

53.75

1.3

1.76

1.78

u/ml

0.02

903

7670

Adrenocortical insufficiency

518

2698

2.46

53.61

1.6

1.3

1.30

1.61

u/ml

0.35

190

700

Other symptoms and signs involving the urinary system

1101

6972

1.77

53.55

1.3

1.13

2.05

u/ml

3.04

425

1819

Dysplasia of cervi uteri

3381

18920

1.40

53.45

1.3

1.60

1.62

u/ml

0.04

993

5309

Tongue abnormality

748

4348

2.05

53.13

1.4

1.3

1.10

1.53

u/ml

0.70

199

1112

Diabetic neuropathy

1199

7779

1.74

52.91

1.6

1.3

1.65

1.69

u/ml

0.04

336

2115

Superficial injury of lower leg

3177

24506

1.40

52.83

1.4

1.3

1.87

1.69

u/ml

0.26

821

6701

Other problems related to primary support group, including family circumstances

1817

12675

1.60

52.64

1.6

1.4

1.81

1.78

u/ml

0.03

474

3388

Transient ischemic attack

5099

33383

1.29

52.51

1.3

1.2

1.32

1.75

u/ml

2.38

1309

8425

Other bullous disorders

395

1874

2.79

52.50

1.9

1.3

6.88

1.77

u/ml

3.61

142

506

Other symptoms and signs involving the circulatory and respiratory systems

795

4677

1.96

52.18

1.4

1.3

1.60

1.86

u/ml

0.20

232

1197

Other diseases of pancreas

868

5230

1.89

52.04

1.4

1.2

1.71

1.68

u/ml

0.02

214

1323

Hernia of abdominal wall

4835

39121

1.30

52.00

1.3

1.64

1.76

u/ml

0.25

1264

10577

Glomerular diseases

1902

13569

1.52

51.63

1.5

1.3

2.03

1.94

u/ml

0.10

536

3548

Other and unspecified rosacea

1078

6940

1.79

51.23

1.4

1.3

1.63

1.68

u/ml

0.05

300

1928

Sequelae of external causes of morbidity and mortality

2792

21197

1.41

51.11

1.3

1.60

1.76

u/ml

0.22

781

5589

Acute pancreatitis

1940

13865

1.51

51.01

1.3

1.76

1.91

u/ml

0.19

513

3708

Graves disease, strict definition

1389

9487

1.68

51.01

1.4

1.3

2.04

1.59

u/ml

0.55

374

2687

Fracture of forearm

7040

54301

1.24

50.96

1.3

1.95

1.63

u/ml

0.98

1726

14513

Coronary atherosclerosis

6490

34038

1.25

50.73

1.3

1.2

1.70

1.80

u/ml

0.22

1708

8488

Fracture of shoulder and upper arm

4109

32746

1.32

50.67

1.3

2.14

1.71

u/ml

0.74

986

8488

Infective dermatitis

1261

8359

1.68

50.55

1.4

1.2

1.51

1.87

u/ml

0.71

389

2209

Neuromuscular dysfunction of bladder

990

6208

1.80

50.55

1.3

1.2

1.43

1.61

u/ml

0.21

202

1652

Disorders of muscles

1159

7538

1.71

50.47

1.3

2.38

1.98

u/ml

0.31

315

2004

Oxycodone

3686

26137

1.34

49.97

1.3

1.2

1.49

1.83

u/ml

1.06

975

6890

Other hammer toe(s) (acquired)

1791

11705

1.53

49.56

1.2

1.56

2.05

u/ml

0.89

396

2928

Speech and linguistic disorders, excluding more controls

1261

7978

1.70

49.32

1.5

1.4

2.24

1.94

u/ml

0.22

285

2099

Adjustment and management of implanted device

1668

11663

1.53

48.95

1.3

1.2

2.04

1.91

u/ml

0.09

310

2948

Lichen planus

1412

9670

1.62

48.90

1.4

1.2

1.46

1.68

u/ml

0.38

397

2515

Suppurative and unspecified otitis media

5285

38656

1.29

48.84

1.4

1.3

2.14

1.62

u/ml

1.41

1346

10867

Unspecified haematuria

3981

26165

1.32

48.74

1.3

1.39

1.90

u/ml

2.40

941

6817

Gonarthrosis,primary

9570

50723

1.20

48.44

1.2

1.69

1.74

u/ml

0.13

2575

13509

Suicide or other Intentional self-harm

3146

24539

1.38

48.40

1.4

1.3

1.33

1.67

u/ml

0.92

741

6975

Intestinal stricture

3051

23557

1.37

48.25

1.3

1.66

1.75

u/ml

0.13

774

6093

Other follicular disorders

969

6186

1.82

48.16

1.4

1.3

1.32

1.58

u/ml

0.31

306

1714

Plantar fascial fibromatosis

1144

7520

1.71

48.09

1.3

1.2

1.80

1.77

u/ml

0.02

276

2025

Retention of urine

3031

19057

1.37

48.08

1.3

1.2

1.60

1.91

u/ml

0.82

754

4913

Superficial injury of wrist and hand

2705

20732

1.42

48.02

1.4

1.3

1.71

1.73

u/ml

0.02

663

5678

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

7881

53325

1.22

47.91

1.3

1.42

1.57

u/ml

0.58

2387

14906

Otalgia

1072

7031

1.77

47.89

1.4

0.97

1.75

u/ml

3.38

231

1787

Fracture of lower leg, including ankle

6601

54992

1.24

47.85

1.3

2.01

1.66

u/ml

0.99

1657

14903

Other hearing loss

2574

18957

1.40

47.82

1.3

1.2

1.45

1.82

u/ml

1.18

629

4699

Other viral diseases, not elsewhere classified

3579

28276

1.35

47.81

1.4

1.3

1.37

1.82

u/ml

1.55

996

7660

Spondyloarthritis

2009

14639

1.48

47.71

1.3

1.35

1.83

u/ml

1.05

547

4075

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

831

5060

1.86

47.66

1.3

1.2

2.57

1.57

u/ml

0.77

210

1275

Other protozoal intestinal diseases

258

1079

3.58

47.64

1.5

1.3

2.49

1.94

u/ml

0.13

268

Ocular pain

1120

7423

1.74

47.54

1.4

1.3

1.06

1.54

u/ml

1.31

279

2031

Spondylopathies (FG)

1684

11976

1.54

47.39

1.3

1.26

1.89

u/ml

1.54

465

3366

Keratitis

4200

33899

1.31

47.27

1.3

1.80

1.68

u/ml

0.22

1230

9275

Bacterial infection, other or unspecified

6225

43961

1.24

47.24

1.3

1.61

1.74

u/ml

0.37

1413

11524

Other disorders of skin and subcutaneous tissue, not elsewhere classified

1542

10788

1.56

46.91

1.4

1.2

1.91

1.85

u/ml

0.05

326

2827

Otitis externa

2650

20284

1.41

46.74

1.4

1.3

1.53

1.77

u/ml

0.47

604

5492

Sulfasalazine

3356

26428

1.35

46.40

1.3

1.22

1.83

u/ml

3.14

887

7309

Striking against or struck by other objects

4095

33045

1.31

46.14

1.4

1.3

1.99

1.75

u/ml

0.47

898

9098

Viral warts

2787

21576

1.40

46.02

1.4

1.3

1.63

1.73

u/ml

0.17

782

5924

Psoriatic and enteropathic arthropathies

1347

9236

1.61

45.93

1.3

1.2

1.38

1.92

u/ml

0.75

369

2578

Angina pectoris

5497

30200

1.26

45.87

1.3

1.2

1.28

1.84

u/ml

3.54

1539

7339

Mental and behavioural disorders due to alcohol

5611

44827

1.25

45.66

1.3

1.51

1.84

u/ml

1.14

1415

12583

Schizophrenia or delusion, excluding more controls

3541

27818

1.33

45.50

1.4

1.3

1.92

1.74

u/ml

0.27

909

8147

Explicit Sepsis

4615

35120

1.28

45.50

1.3

1.79

1.77

u/ml

0.04

1181

9161

Fracture of femur

2448

16675

1.40

45.48

1.3

1.2

1.61

1.86

u/ml

0.49

617

4046

Glaucoma

5586

39883

1.25

45.34

1.3

1.2

1.60

1.69

u/ml

0.19

1548

9975

Other specified and unspecified personality disorders

1194

8085

1.68

45.10

1.4

1.3

0.94

1.60

u/ml

2.97

300

2295

Dislocation, sprain and strain of joints and ligaments at neck level

2007

14895

1.48

45.03

1.4

1.3

1.38

1.65

u/ml

0.45

558

4175

Bulimia nervosa (incl. atypical)

634

3781

2.17

44.98

1.5

1.3

0.81

1.93

u/ml

3.36

163

1059

Disorders of continuity of bone

1204

8158

1.66

44.82

1.4

1.3

1.35

1.78

u/ml

0.82

301

2177

Excessive earwax

5952

48699

1.24

44.74

1.3

1.42

1.76

u/ml

1.90

1756

12470

Other disorders of adrenal gland

630

3696

2.08

44.57

1.6

1.4

1.30

1.91

u/ml

0.98

212

947

Endometriosis ASRM stages 1,2

2495

19212

1.43

44.54

1.3

1.31

1.52

u/ml

0.51

710

5530

Appendectomy

8445

69777

1.20

44.54

1.3

1.65

u/ml

0.01

2421

19469

Disorders of calcium metabolism

733

4420

1.91

44.51

1.3

1.11

1.54

u/ml

0.67

195

1148

Bacterial infection, other or unspecified

5595

40380

1.25

44.50

1.3

1.58

1.73

u/ml

0.40

1224

10545

Substance use, excluding alcohol

2411

18342

1.42

44.28

1.4

1.3

1.87

1.79

u/ml

0.08

540

5226

Sequelae with surgical and medical care as external cause

2145

16017

1.44

44.28

1.3

1.57

1.78

u/ml

0.25

597

4183

Other noninflammatory disorders of uterus, except cervix

2379

12045

1.43

44.18

1.3

1.2

1.23

1.72

u/ml

1.47

626

3147

Neuralgia and neuritis, unspecified

614

3538

2.03

44.02

1.4

1.2

0.77

1.60

u/ml

3.17

152

923

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

501

2702

2.17

43.85

1.3

1.2

0.87

1.89

u/ml

3.18

107

680

Raynaud syndrome

1130

7631

1.70

43.85

1.4

1.3

1.47

1.43

u/ml

0.03

304

2100

Other disorders of penis

878

5494

1.76

43.81

1.3

1.87

2.31

u/ml

0.40

204

1452

Unspecified mental disorder

5047

41876

1.27

43.49

1.4

1.3

1.56

1.70

u/ml

0.31

1307

11886

Hypoparathyroidism

480

2611

2.30

43.45

1.4

1.3

0.84

1.69

u/ml

2.06

148

654

Other bacterial diseases

12892

72495

1.16

43.41

1.3

1.72

u/ml

0.02

3289

19922

Dermatitis herpetiformis

274

1216

3.12

43.33

2.1

1.3

8.32

1.63

u/ml

3.86

111

318

Ventral hernia

2441

18579

1.40

43.33

1.3

1.2

1.59

1.78

u/ml

0.28

635

4981

Mental and behavioural disorders due to alcohol, excluding acute intoxication

4636

37851

1.27

43.27

1.3

1.58

1.83

u/ml

0.63

1174

10611

Lesion of ulnar nerve

1467

10314

1.55

43.25

1.3

1.2

1.86

1.98

u/ml

0.10

417

2828

L04AD Calcineurin inhibitors

1297

8994

1.62

43.08

1.4

1.3

1.41

2.02

u/ml

0.96

316

2333

Anogenital herpesviral [herpes simplex] infection

1637

11923

1.55

43.02

1.4

1.3

1.51

1.56

u/ml

0.04

413

3502

Charcot foot

247

1036

3.18

42.99

1.7

1.2

1.62

1.40

u/ml

0.16

277

Disorders of breast

6662

51597

1.23

42.87

1.3

1.28

1.53

u/ml

1.04

1801

14277

Benign neoplasm: Descending colon

708

4266

1.90

42.64

1.3

1.2

2.36

1.41

u/ml

0.50

193

1099

Problems related to lifestyle

1276

8801

1.60

42.51

1.4

1.3

1.18

1.80

u/ml

1.25

350

2434

Nummular dermatitis

864

5475

1.78

42.48

1.4

1.2

1.65

1.70

u/ml

0.04

244

1433

Open wound of head

5942

48173

1.23

42.37

1.3

2.01

1.85

u/ml

0.35

1461

12843

Acute appendicitis, no complications

7043

59996

1.22

42.37

1.3

1.63

1.70

u/ml

0.18

2030

16972

Intestinal adhesions without obstruction

803

4966

1.79

42.36

1.3

1.2

1.86

1.96

u/ml

0.07

175

1338

SLE (Finngen)

457

2456

2.28

42.16

1.4

1.2

1.32

1.30

u/ml

0.01

106

637

Diplopia

1426

10049

1.56

42.15

1.3

2.01

1.88

u/ml

0.08

371

2661

Acute gastritis

766

4699

1.82

42.15

1.3

1.2

2.34

1.90

u/ml

0.26

216

1258

Early onset COPD, excluding more controls

1883

13782

1.45

42.08

1.3

1.2

1.59

2.01

u/ml

0.75

444

3801

Rheumatoid arthritis, including avohilmo

4210

34405

1.29

42.02

1.3

1.16

1.70

u/ml

3.41

1122

9122

Mixed connective tissue disease

808

5116

1.85

41.93

1.4

1.3

1.97

1.56

u/ml

0.34

214

1370

Atrophic disorders of skin

1781

13108

1.49

41.85

1.3

1.73

1.63

u/ml

0.12

477

3510

Diseases of appendix

9396

74010

1.18

41.65

1.3

1.70

1.67

u/ml

0.08

2664

20592

Psoriatic arthropathies

1121

7553

1.64

41.53

1.3

1.2

1.48

2.15

u/ml

0.82

319

2075

Abnormal findings on diagnostic imaging of other body structures

1524

10915

1.53

41.43

1.3

1.85

1.73

u/ml

0.12

399

2935

Agoraphobia

530

3038

2.19

41.40

1.4

1.3

1.48

1.23

u/ml

0.25

103

879

Seborrhoeic dermatitis

1011

6685

1.68

40.99

1.4

1.3

1.51

1.77

u/ml

0.39

282

1735

Dissociative [conversion] disorders

605

3607

2.06

40.95

1.5

1.3

2.24

1.54

u/ml

0.41

183

1005

Unspecified urinary incontinence

1030

6894

1.68

40.54

1.4

1.3

1.63

1.50

u/ml

0.14

129

1760

Vulvovaginal ulceration/inflammation in other diseases

928

6169

1.78

40.47

1.4

1.3

1.60

1.58

u/ml

0.01

245

1757

Secondary hypertension

852

5351

1.75

40.45

1.4

1.3

2.02

2.07

u/ml

0.03

215

1350

Disorders of psychological development

1900

13245

1.48

40.33

1.5

1.4

1.94

2.04

u/ml

0.09

433

3357

Fracture of foot, except ankle

3015

23921

1.35

40.28

1.4

1.3

2.05

1.67

u/ml

0.64

733

6734

Appendicitis, broad definition

9311

73729

1.18

40.25

1.3

1.69

1.67

u/ml

0.06

2645

20523

Alcohol abuse, main dg, excluding more controls

1588

11449

1.50

40.22

1.3

1.16

1.84

u/ml

3.36

374

3328

Gout, FINNGEN

2331

17667

1.38

40.16

1.2

2.07

1.86

u/ml

0.23

538

4444

Hyperparathyroidism

1843

13464

1.45

40.11

1.3

1.2

1.50

1.67

u/ml

0.23

436

3376

Gout, idiopatic and unspecified

2011

14996

1.42

39.92

1.2

2.26

1.90

u/ml

0.38

457

3807

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

683

4200

1.92

39.84

1.4

1.3

1.38

1.67

u/ml

0.35

182

1090

Lactose intolerance, other/unspecified

413

2210

2.37

39.67

1.5

1.3

1.36

1.82

u/ml

0.43

565

Hypermobility syndrome

835

5459

1.84

39.66

1.4

1.3

0.88

1.41

u/ml

0.77

268

1529

Cholangitis (primary sclerosing, PSC)

671

4062

1.88

39.63

1.4

1.3

1.93

1.89

u/ml

0.02

154

1025

Vitamin deficiency

592

3493

1.99

39.61

1.4

1.3

1.95

1.60

u/ml

0.19

162

907

Vitamin deficiency, wide

592

3493

1.99

39.61

1.4

1.3

1.95

1.60

u/ml

0.19

162

907

Malignant neoplasm of respiratory system and intrathoracic organs

887

11334

0.62

39.60

1.2

2.38

1.85

u/ml

0.50

179

2880

Other specified/unspecified systemic involvement of connective tissue

728

4553

1.87

39.59

1.4

1.3

2.14

1.58

u/ml

0.43

190

1222

Diseases of arteries, arterioles and capillaries

6525

40960

1.22

39.51

1.3

1.2

1.65

1.74

u/ml

0.22

1624

10549

Acute tubulo-interstitial nephritis

7535

56105

1.20

39.50

1.3

1.49

1.70

u/ml

0.86

1934

14917

Other noninflammatory disorders of vagina

986

6581

1.69

39.40

1.3

1.51

1.75

u/ml

0.31

265

1759

Drug-induced osteoporosis with pathological fracture

243

1073

3.19

39.26

1.5

1.3

0.82

1.48

u/ml

1.07

270

Sequelae of injuries, of poisoning and of other consequences of external causes

2603

20300

1.37

39.25

1.3

2.34

1.67

u/ml

0.91

599

5643

Polymyalgia rheumatica

1193

8194

1.58

39.18

1.3

1.2

1.24

1.68

u/ml

1.25

288

2025

Other disorders of bone

2353

18164

1.39

39.01

1.4

1.3

1.81

1.72

u/ml

0.11

621

4994

Alcohol use disorder, ICD-based

4270

35126

1.27

38.98

1.3

1.59

1.83

u/ml

0.54

1091

9825

2425

16182

1.37

38.86

1.2

1.70

1.87

u/ml

0.24

605

3727

Adalimumab

1250

8799

1.60

38.83

1.3

1.37

1.70

u/ml

0.44

357

2460

Acute pancreatitis (for exclusion)

1940

14515

1.43

38.69

1.3

1.76

1.93

u/ml

0.22

513

3834

Glucosamine medication

4613

30459

1.26

38.67

1.3

1.2

1.29

1.74

u/ml

1.74

1095

7511

Other bacterial diseases

11397

67921

1.16

38.36

1.3

1.70

1.74

u/ml

0.13

2789

18604

Emotional disorders and disorders of social functioning with onset specific to childhood

973

6564

1.77

38.24

1.7

1.5

1.63

1.91

u/ml

0.27

206

1609

Autoimmune hepatitis

162

604

4.36

38.09

1.5

1.2

1.35

0.67

u/ml

1.31

161

Pacemaker

2727

20437

1.34

38.03

1.3

1.2

1.84

1.85

u/ml

0.01

721

4881

Nail disorders

995

6709

1.67

38.01

1.4

1.3

1.31

1.80

u/ml

1.14

283

1796

False labour

4697

24489

1.28

37.87

1.3

1.27

1.58

u/ml

1.26

1470

7115

Dermatophytosis

1313

9283

1.54

37.74

1.4

1.3

2.18

1.94

u/ml

0.21

379

2413

Contact with and exposure to communicable diseases

4582

38192

1.27

37.74

1.4

1.3

1.18

1.68

u/ml

3.16

2016

10361

Localized swelling, mass and lump of skin and subcutaneous tissue

3500

28379

1.30

37.73

1.3

1.51

1.79

u/ml

0.78

872

7632

Other/unspecified enthesopathies of lower limb, excluding foot

849

5528

1.73

37.65

1.4

1.3

0.86

2.03

u/ml

5.73

219

1476

Other septicaemia

3728

29164

1.28

37.51

1.3

1.70

1.84

u/ml

0.27

915

7470

Gout, unspecified

1646

12019

1.45

37.51

1.2

2.22

1.94

u/ml

0.24

365

3021

Influenza and pneumonia

14043

80250

1.14

37.51

1.3

1.74

1.71

u/ml

0.09

3604

22078

Other abnormal immunological findings in serum

335

1728

2.64

37.34

1.8

1.4

6.36

2.07

u/ml

2.64

104

446

Ulcerative proctitis

789

5092

1.78

37.31

1.3

1.94

1.63

u/ml

0.17

184

1413

Oesophagitis

556

3243

1.95

37.30

1.3

1.2

1.45

1.95

u/ml

0.74

134

864

Coagulation defects, purpura and other haemorrhagic conditions

2181

16759

1.40

37.28

1.4

1.3

1.91

1.82

u/ml

0.12

565

4485

Acute appendicitis

8715

71391

1.18

37.26

1.3

1.73

1.67

u/ml

0.14

2482

19944

Flat foot [pes planus] (acquired)

1104

7606

1.61

37.20

1.3

1.2

1.67

1.97

u/ml

0.25

305

2011

Redundant prepuce, phimosis and paraphimosis

1867

13775

1.42

37.13

1.3

1.99

1.96

u/ml

0.03

518

3872

Enterocolitis due to Clostridium difficile

1051

7128

1.61

37.11

1.3

1.2

1.47

u/ml

0.00

234

1835

Superficial injury of head

2671

21029

1.35

37.10

1.3

1.45

1.80

u/ml

0.96

603

5565

Erysipelas

7977

52894

1.19

36.91

1.3

1.60

1.75

u/ml

0.58

2120

14365

Atypical facial pain

646

3989

1.90

36.89

1.4

1.2

1.62

1.48

u/ml

0.08

166

1064

Hypopituitarism

864

5702

1.73

36.72

1.4

1.16

2.01

u/ml

2.18

260

1440

Glaucoma suspect

3572

29074

1.29

36.68

1.3

1.2

1.63

1.72

u/ml

0.15

1044

7338

Malignant neoplasm of bronchus and lung

747

9721

0.60

36.67

1.2

2.35

1.78

u/ml

0.49

147

2476

Nonalcoholic steatohepatitis

159

602

4.36

36.63

1.4

1.3

1.01

2.06

u/ml

0.81

168

Acute suppurative otitis media

3921

30257

1.29

36.50

1.4

1.3

2.43

1.66

u/ml

1.72

1020

8493

Certain disorders involving the immune mechanism

2060

15752

1.40

36.43

1.3

2.24

1.78

u/ml

0.54

520

4287

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

3599

29448

1.29

36.40

1.3

1.58

1.72

u/ml

0.29

943

8231

Complications of internal orthopaedic prosthetic devices, implants and grafts

2128

16283

1.39

36.26

1.3

1.2

1.59

1.93

u/ml

0.56

526

4125

Diabetic nephropathy, excluding more controls

1556

9373

1.49

36.22

1.6

1.3

2.07

1.49

u/ml

1.07

470

2449

Septicaemia

4212

32579

1.26

35.96

1.3

1.87

1.81

u/ml

0.11

1029

8344

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

1063

7337

1.62

35.93

1.4

1.3

1.55

1.57

u/ml

0.02

277

1978

Other predominantly sexually transmitted diseases, not elsewhere classified

2977

24018

1.33

35.85

1.4

1.3

1.72

1.52

u/ml

0.31

780

7024

Other and unspecified tonsillitis

4710

33222

1.25

35.84

1.4

1.3

1.57

1.76

u/ml

0.50

1335

9398

D07AA Corticosteroids, weak (group I)

2076

15984

1.41

35.79

1.4

1.3

2.18

1.82

u/ml

0.44

562

4291

Acne

1621

12128

1.49

35.71

1.5

1.4

1.71

1.74

u/ml

0.04

471

3283

Erysipelas

5708

42910

1.22

35.60

1.3

1.2

1.65

1.76

u/ml

0.28

1478

11447

Scoliosis

1153

8129

1.59

35.51

1.4

1.57

1.80

u/ml

0.25

298

2060

Childhood allergy (age < 16)

2665

17584

1.37

35.41

1.5

1.4

2.12

1.82

u/ml

0.50

661

4608

1730

12057

1.42

35.34

1.3

1.2

1.74

1.87

u/ml

0.14

439

2742

Endometriosis of rectovaginal septum and vagina

929

6270

1.67

35.22

1.3

1.04

1.88

u/ml

2.10

272

1667

Other and unspecified visual disturbances

1163

8194

1.57

35.19

1.3

3.08

1.76

u/ml

1.03

264

2152

Conduction disorders

2830

18174

1.32

35.15

1.3

1.83

1.96

u/ml

0.19

702

4519

Other complications of surgical and medical care, not elsewhere classified

1157

8149

1.57

35.05

1.4

1.3

1.34

1.75

u/ml

0.48

307

2183

Gout, strict definition

1418

10227

1.47

34.85

1.3

1.2

2.13

2.00

u/ml

0.10

321

2575

Disorders of refraction and accommodation

3494

28573

1.29

34.79

1.4

1.3

1.95

1.87

u/ml

0.10

935

7698

Primary hyperparathyroidism

1162

8201

1.57

34.67

1.3

1.2

1.21

1.58

u/ml

0.67

283

2136

Supplementary factors related to causes of morbidity and mortality classified elsewhere

3646

29992

1.28

34.56

1.3

1.79

1.68

u/ml

0.18

1238

8053

Other disorders starting during childhood or adolecense, excluding more controls

808

5158

1.77

34.54

1.6

1.5

2.20

2.12

u/ml

0.04

181

1301

Hypertrophy of breast in women and men

2482

19659

1.36

34.49

1.3

1.06

1.60

u/ml

3.23

765

5594

Presbycusis

1076

7302

1.55

34.46

1.3

1.2

1.54

1.63

u/ml

0.10

238

1675

Other female pelvic inflammatory diseases

1994

15384

1.41

34.41

1.3

0.99

1.57

u/ml

2.34

480

4249

ILD, hospital admission 2, with pulmonary infections

872

5765

1.65

34.37

1.3

1.2

1.36

1.99

u/ml

1.29

225

1464

Kela-code for severe mental illness

4336

36278

1.25

34.26

1.3

1.64

1.67

u/ml

0.04

1165

10248

Reactive arthropathies

973

6635

1.62

34.19

1.3

1.83

2.18

u/ml

0.34

248

1780

Presence of other devices

2191

16857

1.36

34.17

1.3

1.2

2.44

1.89

u/ml

0.87

543

4240

Postprocedural disorders of nervous system

1013

7055

1.64

34.12

1.4

1.3

1.49

1.47

u/ml

0.01

302

1993

Cluster headache, wide

502

2956

2.00

34.08

1.4

1.3

0.99

1.80

u/ml

1.74

136

817

Other/unspecified enthesopathies, not elsewhere classified

872

5800

1.65

34.06

1.3

1.2

1.28

1.97

u/ml

1.46

232

1542

Other bursopathies

1271

9073

1.51

34.01

1.3

1.2

1.66

2.06

u/ml

0.52

321

2369

Disorder of lipoprotein metabolism, unspecified

1182

8314

1.53

33.99

1.3

1.2

1.74

1.88

u/ml

0.13

289

2144

Lichen sclerosus et atrophicus

1183

8429

1.56

33.88

1.3

1.54

1.65

u/ml

0.10

328

2227

Malignant neoplasm of bronchus and lung, including Hilmo

956

11716

0.65

33.76

1.2

2.09

1.82

u/ml

0.26

203

2980

Presence of cardiac and vascular implants and grafts

3788

23071

1.26

33.62

1.2

1.78

1.95

u/ml

0.33

845

5680

Colectomy operation

1589

11803

1.44

33.56

1.3

1.2

2.25

1.90

u/ml

0.28

385

3010

Palmar fascial fibromatosis [Dupuytren]

1185

8324

1.51

33.37

1.3

1.2

2.35

2.22

u/ml

0.08

265

2070

Chronic periodontitis, complicated

5613

47590

1.21

33.34

1.3

1.59

1.69

u/ml

0.26

1247

12938

Type of accident

3360

27525

1.29

33.23

1.3

1.72

1.73

u/ml

0.01

1150

7420

Superficial injury of abdomen, lower back and pelvis

1779

13516

1.42

33.20

1.4

1.3

1.48

1.77

u/ml

0.51

463

3638

Superficial injury of thorax

1572

11708

1.44

32.99

1.4

1.3

1.75

1.89

u/ml

0.15

400

3096

Umbilical hernia

2679

21369

1.32

32.94

1.3

1.77

1.87

u/ml

0.15

718

5892

Combinations of oral blood glucose lowering drugs

2535

20069

1.33

32.92

1.3

1.2

1.60

1.93

u/ml

0.58

717

5259

Excessive vomiting in pregnancy

1172

8450

1.57

32.90

1.4

1.3

1.56

1.59

u/ml

0.03

331

2409

Other viral diseases

3814

31638

1.27

32.88

1.4

1.3

1.40

1.81

u/ml

1.41

1051

8609

AV-block

1499

9609

1.44

32.84

1.2

1.88

1.91

u/ml

0.03

356

2331

Female infertility, associated with anovulation

1195

8618

1.55

32.82

1.3

1.14

1.66

u/ml

1.43

471

2550

Other specified/unspecified bacterial intestinal infections

725

4712

1.74

32.56

1.4

1.3

2.22

1.49

u/ml

0.43

154

1233

Any event in hilmo or specialist outpatient

106

146

4.63

32.46

1.3

1.1

1.04

1.12

u/ml

0.06

Oral lichen planus, including avohilmo , including avohilmo

754

4972

1.73

32.44

1.3

2.02

1.62

u/ml

0.31

211

1336

Other Crohn's disease

868

5898

1.66

32.27

1.3

0.78

1.65

u/ml

5.12

199

1636

Misadventures to patients during surgical and medical care

1521

11331

1.45

32.21

1.3

1.32

1.75

u/ml

0.90

358

3044

Rash and other nonspecific skin eruption

1098

7779

1.56

32.18

1.4

1.3

2.45

1.93

u/ml

0.41

316

2033

Seropositive rheumatoid arthritis

2588

20549

1.32

32.10

1.3

1.2

1.12

1.75

u/ml

3.20

676

5377

L04AC Interleukin inhibitors

738

4864

1.74

32.05

1.3

1.10

1.59

u/ml

0.58

209

1362

Volume depletion

867

5809

1.62

32.01

1.4

1.3

1.27

1.87

u/ml

0.79

253

1453

Pediculosis, acariasis and other infestations

2110

16547

1.38

31.88

1.4

1.3

1.73

1.68

u/ml

0.06

583

4501

Herpesviral [herpes simplex] infections

1357

9985

1.49

31.83

1.3

1.85

1.70

u/ml

0.15

367

2734

Primary adrenocortical insufficiency

190

837

3.35

31.73

1.9

1.3

1.62

1.91

u/ml

0.12

234

Cluster headache, strict

470

2777

2.00

31.69

1.4

1.3

1.01

1.78

u/ml

1.49

125

778

Gluteal tendinitis

475

2812

1.99

31.60

1.3

1.2

1.82

1.97

u/ml

0.09

115

715

Ankylosing spondylitis

931

6381

1.60

31.59

1.3

1.17

1.88

u/ml

1.48

235

1725

Acne vulgaris

1274

9383

1.53

31.56

1.5

1.4

1.53

1.71

u/ml

0.29

383

2561

Hepatic failure, not elsewhere classified

410

2320

2.07

31.44

1.4

1.2

3.60

1.63

u/ml

0.68

621

Superficial injury of hip and thigh

1481

10997

1.44

31.22

1.3

2.17

1.78

u/ml

0.41

363

2832

Acute pharyngitis

2025

15716

1.38

30.83

1.4

2.10

1.82

u/ml

0.34

545

4259

ILD, hospital admissions

1290

9380

1.47

30.80

1.3

1.2

1.21

1.77

u/ml

1.74

316

2344

Sleep disorders, other/unspecified

514

3167

1.96

30.69

1.5

1.3

1.24

1.70

u/ml

0.57

113

843

Alopecia areata

393

2262

2.19

30.60

1.5

1.3

2.43

1.72

u/ml

0.24

113

600

Other disorders of nervous system

680

4407

1.73

30.57

1.3

1.2

1.82

1.53

u/ml

0.16

156

1146

Anomalies of dental arch relationship, including avohilmo

2745

20120

1.32

30.47

1.4

1.78

1.80

u/ml

0.02

727

5423

Drug-induced hypoglycaemia without coma

218

1009

2.79

30.46

1.8

1.2

2.48

1.24

u/ml

0.48

269

Scabies

1844

14317

1.40

30.44

1.4

1.3

1.66

1.71

u/ml

0.05

516

3912

Abnormal findings in secretions and smears from cervix uteri vagina vulva

6995

46397

1.19

30.41

1.3

1.39

1.48

u/ml

0.31

2091

13205

Other disorders of kidney and ureter

1249

9092

1.48

30.34

1.3

2.01

2.11

u/ml

0.07

271

2353

Oligomenorrhoea

519

3209

1.93

30.28

1.4

1.3

1.78

1.96

u/ml

0.08

145

883

Emotional disorders starting during childhood or adolescence

905

6364

1.69

30.28

1.7

1.5

1.75

1.97

u/ml

0.19

197

1506

Varicose veins

6507

42695

1.19

30.12

1.3

1.2

1.46

1.69

u/ml

0.92

1865

11297

Thyroiditis

879

6095

1.63

29.84

1.4

1.3

1.85

1.51

u/ml

0.27

237

1653

Interstitial lung disease

1300

9516

1.46

29.76

1.3

1.2

1.23

1.75

u/ml

1.57

319

2376

Interstitial lung disease endpoints

1300

9516

1.46

29.76

1.3

1.2

1.23

1.75

u/ml

1.57

319

2376

Other endocrine disorders

788

5177

1.71

29.74

1.5

1.6

1.07

2.47

u/ml

4.12

188

1153

Other interstitial pulmonary diseases

1300

9517

1.46

29.74

1.3

1.2

1.23

1.75

u/ml

1.57

319

2377

Other and unspecified drugs and medicaments

966

6796

1.58

29.67

1.4

1.3

1.58

1.45

u/ml

0.11

260

1807

Ethmoidectomy

1421

10630

1.45

29.66

1.3

1.71

1.80

u/ml

0.08

390

2951

Fracture at wrist and hand level

3979

33397

1.24

29.57

1.3

1.80

1.74

u/ml

0.09

1000

9249

Other specified/unspecified inflammatory spondylopathies

600

3831

1.79

29.56

1.3

1.64

1.66

u/ml

0.01

186

1082

Seronegative rheumatoid arthritis

1211

8814

1.49

29.52

1.3

1.2

1.61

1.82

u/ml

0.23

311

2310

Anosmia

256

1211

2.40

29.51

1.3

1.2

1.62

2.80

u/ml

0.82

318

Nasal polyp

1797

13824

1.37

29.42

1.3

1.2

1.97

1.90

u/ml

0.06

460

3814

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Tissue transglutaminase IgA Ab [Units/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS